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demonstrated that the stem cell niche, or local tissue microenvironment, provides important extracellular cues
to guide stem cell behaviors. The Drosophila male germline system has emerged as an exemplary model for
studying stem cell-niche biology. The apically located hub cells function as a shared niche for two stem cell
populations: germline stem cells (GSCs) and cyst stem cells (CySCs). A dominant model in the field
describes hub cells as the single niche for GSCs via promoting JAK-STAT signaling. However, recent work
from our lab has demonstrated that BMP signaling is the primary pathway leading to GSC self-renewal. We
have also revealed that CySCs function as a second niche to govern GSC maintenance. In this thesis, we
identify Magu as a novel regulator controlling GSC self-renewal. We show that Magu is expressed from hub
cells, and specifically required for GSC maintenance. We also show that Magu acts as an extracellular BMP
modulator through interaction with Dally-like, a heparan sulfate proteoglycan. Our characterization of Magu
further emphasizes the importance of BMP signaling in male GSC maintenance.
Zfh1 is a transcription factor expressed in CySCs. Zfh1 is required for CySC maintenance, and can also induce
ectopic GSCs non-autonomously. Thus, Zfh1 exerts an impact on two stem cell lineages, matching with our
recent notion that CySCs function as both a stem cell and a niche for GSCs. To dissect out how Zfh1 controls
stem cell self-renewal, we attempt to identify target genes of Zfh1 using two genome-wide approaches: ChIP-
Seq and a genetic modifier screen. Preliminary results show that eya and shg may be direct targets of Zfh1, and
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ABSTRACT 
 
NOVEL REGULATORS IN THE GERMLINE STEM CELL  
NICHE OF DROSOPHILA TESTIS 
Qi Zheng 
Stephen DiNardo 
      Stem cells are powerful and promising tools in regenerative medicine. Understanding how 
stem cells are maintained in vivo is crucial for their clinical application. Studies on various stem 
cell systems have demonstrated that the stem cell niche, or local tissue microenvironment, 
provides important extracellular cues to guide stem cell behaviors. The Drosophila male germline 
system has emerged as an exemplary model for studying stem cell-niche biology. The apically 
located hub cells function as a shared niche for two stem cell populations: germline stem cells 
(GSCs) and cyst stem cells (CySCs). A dominant model in the field describes hub cells as the 
single niche for GSCs via promoting JAK-STAT signaling. However, recent work from our lab has 
demonstrated that BMP signaling is the primary pathway leading to GSC self-renewal. We have 
also revealed that CySCs function as a second niche to govern GSC maintenance. In this thesis, 
we identify Magu as a novel regulator controlling GSC self-renewal. We show that Magu is 
expressed from hub cells, and specifically required for GSC maintenance. We also show that 
Magu acts as an extracellular BMP modulator through interaction with Dally-like, a heparan 
sulfate proteoglycan. Our characterization of Magu further emphasizes the importance of BMP 
signaling in male GSC maintenance.  
      Zfh1 is a transcription factor expressed in CySCs. Zfh1 is required for CySC maintenance, 
and can also induce ectopic GSCs non-autonomously. Thus, Zfh1 exerts an impact on two stem 
cell lineages, matching with our recent notion that CySCs function as both a stem cell and a niche 
for GSCs. To dissect out how Zfh1 controls stem cell self-renewal, we attempt to identify target 
genes of Zfh1 using two genome-wide approaches: ChIP-Seq and a genetic modifier screen. 
Preliminary results show that eya and shg may be direct targets of Zfh1, and CtBP is required for 
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Zfh1 function. This ongoing project will further elucidate the dual role of CySCs, and advance our 
understanding of the complex niche signals regulating stem cells. 
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Stem cells  
      Stem cells exist throughout development and adulthood. The hallmarks of stem cells 
comprise both self-renewal and differentiation (1). The characteristic of self-renewal 
allows stem cells to perpetuate themselves by proliferation, even after long periods of 
inactivity. Their ability to produce differentiated cells makes stem cells produce 
specialized progeny for the tissue, responding to either physiological disturbance or tissue 
damage.  
      Based on the differentiation potential, stem cells can be categorized into three types. 
The totipotent stem cell often refers to zygote, which has the ability to give rise to all 
cells of an organism (2). The power of totipotent stem cell is enormous, as an individual 
human zygote can develop into an adult with 37.2 trillion cells (3). A pluripotent stem 
cell is an embryonic stem cell, derived from the inner cell mass of an embryo (2). 
Embryonic stem cells can produce all cells of an embryo, but not extra-embryonic tissues 
(2). The last type of stem cell is the adult stem cell, which only generates the specialized 
cell types for the tissue it resides in. Adult stem cells are maintained throughout life, and 
have been identified in many body parts, including skin, gut, brain, liver, bone marrow, 
skeletal muscle, and testis (1). I will focus on adult stem cells for the rest of my 
discussion. 
      The first difficulty in studying stem cells is identifying that stem cells exist for a 
tissue, and determining where they reside. Genetic lineage tracing has become the gold 
standard of identifying stem cells (1). Cells in a living tissue are labeled with molecular 
markers, and the identity of differentiated cells generated by cell division is characterized. 
Alternatively, cells removed from a living animal are labeled in cell culture, and 
transplanted into another animal to examine whether their tissue of origin can be 
reformed in vivo.    
      The unique power of stem cells is the potential that they can be harnessed to repair 
damaged tissues or organs. However, a profound hurdle in such regenerative medicine is 
how to maintain and grow sufficient amount of stem cells in vitro efficiently. Thus, 
understanding how adult stem cells are maintained in vivo can provide us important clues 
to better manipulate them in cell culture.  
      Various models of stem cell maintenance have been identified. Historically, 
asymmetric cell division has been supposed as the key mechanism (4). This model argues 
that the division of stem cell is polarized as stemness determinants are distributed to the 
mother cell but not inherited by the differentiating daughter. A classical example of 
asymmetric cell division is Drosophila neuroblast (1). A series of proteins have been well 
characterized to explain how the polarity is established, the mitotic spindle is oriented, 
and the ultimate cell fate is determined (5). Asymmetric cell division has also been 
observed in several mammalian systems, but its mechanism and influence in stem cell 
maintenance is less well understood (5, 6). Recently, the dynein-binding protein Lis1 was 
implicated in regulating asymmetric division in hematopoietic stem cells. Loss of Lis1 
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causes defective spindle positioning and impaired inheritance of cell fate determinants, 
accelerating cell differentiation (7).  
      In recent years, accumulating evidence has demonstrated that symmetric division can 
play an important role in stem cell maintenance. Contrary to asymmetric division, 
symmetric renewal gives rise to two stem cells. In Drosophila testis, using live imaging 
and lineage tracing, two groups have independently reported symmetric division for 
germline stem cells (GSC) (8, 9). During steady state, the rate of symmetric division is 
very low, however, the frequency increases when GSC depletion is genetically induced or 
a cell adhesion molecule is ectopically expressed (8, 9). Thus, symmetric renewal is not 
prevalent under physiological condition, but becomes critical when tissue homeostasis is 
disturbed experimentally. In contrast to the fly testis, symmetric division occurs more 
frequently in mammalian systems under normal tissue turnover. These systems are often 
constantly cycling, including the mouse hair follicle, intestine, and testis (10-13). 
Symmetric division is usually combined with the model “neutral drift”, which argues that 
stem cell maintenance is stochastic, and when a stem cell is lost, its neighboring stem cell 
can replenish the pool by producing two stem daughter cells (4, 5, 14). The identification 
of symmetric division reveals the dynamic nature of stem cell maintenance, and modifies 
the traditional view of invariant asymmetric renewal.  
      Whether tissue stem cells renew using mostly asymmetric or symmetric divisions, 
identifying the mechanisms at work is essential if we are to achieve the goal of better 
manipulating them in cell culture. Tissue maintenance by stem cells is even more 
complex. For example, the maintenance of stem cells is also contributed by their 
differentiating daughters via a process coined dedifferentiation (15). The cellular 
plasticity of the daughter cells allows them to be converted back to stem cells when 
necessary. In Drosophila testes and ovaries, when the original pool of GSCs was 
removed by transiently driving the differentiation factor Bam, differentiating germ cells 
can revert to GSCs (8, 16). The process of dedifferentiation has also been observed in 
mouse testis and intestine (10, 17). A most recent study also shows that committed 
epithelial cells lining mouse airway can regain stemness in vivo after airway basal stem 
cells are ablated (18). The mechanism by which differentiating cells can switch back into 
stem cells is not clear. As more studies progress, the mechanism of dedifferentiation will 
be further elucidated.  
 
Stem cell niche  
      Regardless of the types of division used by tissue stem cells to renew the pool, one 
still has to identify mechanisms.  Isolated stem cells often lose their capability of self-
renewal outside the body. This suggests that tissues surrounding stem cells are also 
required for stem cell maintenance. Studies from many systems have demonstrated that 
the stem cell niche, or the local tissue microenvironment, provides important extracellular 
cues to guide stem cell behavior. There are two basic types of niche: the stromal niche 
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and the epithelial niche (1). Stromal niche consists of specialized cells. A canonical 
example of stromal niche is the post-mitotic distal tip cell for germline stem cells (GSCs) 
in C. elegans (19). Removal of distal tip cell by laser microsurgery causes all GSCs to 
differentiate (20). In contrast to niches composed of dedicated cells, an epithelial niche 
often lacks a dedicated set of support cells. Rather the niche is formed by basement 
membrane, which is composed of extracellular matrix located at the basal side of 
epithelial tissue. For example, in the Drosophila ovary, the basement membrane directly 
contacts somatic follicle stem cells, and controls stem cell behavior through integrin-
mediated interaction  
(21, 22). Due to complicated anatomical structure, the composition of mammalian stem 
cell niche often appears exceedingly complex and incompletely defined, even though the 
gross niche location is known (1). Take the best understood hematopoietic stem cell 
(HSC) niche as an example. After more than ten years of experimentation, a model of 
two distinct niches has been proposed: the endosteal niche houses quiescent HSCs, 
whereas the perivascular niche supports active HSCs. Previous studies have defined 
multiple niche components including sinusoidal endothelial cells, sympathetic nerve 
fibers, and cells of the osteoblastic lineage (23). Recent work identifies two new players: 
perivascular mesenchymal stem cells and macrophages, which are important to regulate 
the mobilization of HSCs between the two niches (23).  
      Niche cells often secrete cytokines, and regulate stem cells through signaling 
pathways (1). The focus of my thesis is how these extrinsic signals control stem cell 
behaviors. Thus, later in this chapter, I will discuss various signals using the Drosophila 
testis as a model. It is also interesting to point out that stem cells and their niche are often 
anchored to each other by adhesion molecules. In Drosophila ovary, E-cadherin is 
required for niche occupancy of the germline stem cell (GSC), and GSCs expressing 
more E-cadherin can outcompete wildtype stem cells (24, 25). Stem cell anchorage is 
crucial not only under physiological condition, but also during the trafficking of 
transplanted stem cells to the niche. For example, it has been demonstrated that integrin is 
required for transplanted hematopoietic stem cells and spermatogonial stem cells to home 
to the niche (26-29).     
 
The stem cell system in Drosophila testis  
      The Drosophila testis has emerged as a valuable model to study adult stem cells 
(Fig.1). The existence and location of stem cells in the system have long been proposed 
since 1970s, based on electron microscopy studies and structural organization of 
spermatogenesis (30). However, the definitive identity of stem cells was not established 
until lineage tracing approach was applied. Using FLP/FRT-mediated recombination, 
Gönczy and DiNardo labeled individual somatic or germline cell with LacZ expression at 
the apex of the tubular testis. They demonstrated that the LacZ+ cell can not only remain 
in the presumptive stem cell location, but also produce progeny present in all stages of 
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spermatogenesis (31). Thus, there exist two stem cell populations in the testis: germline 
stem cells (GSCs), and accompanying cyst stem cells (CySCs). The two types of stem 
cells are radially arranged around the hub, a shared niche composed of post-mitotic 
somatic cells. Upon asymmetric division (32), GSC generates two daughter cells, one 
remains attached to the hub, and the other undergoes differentiation as a gonialblast (GB). 
GB divides mitotically four rounds with incomplete cytokinesis, giving rise to a cyst of 
16 interconnected spermatogonia. Terminal differentiation is initiated in spermatogonia 
to produce spermatocytes, which then enter meiosis to generate 64 spermatids (33). 
Asymmetric division also occurs in CySCs (34), as one daughter cell stays associated 
with the hub and GSCs, whereas the other differentiates as a somatic cyst cell. A pair of 
differentiating cyst cells continues to embrace the cyst of spermatogoina. While encysted 
gonial cells undergo cell division, cyst cells do not divide any longer, they rather increase 
in size in order to accommodate the tremendous growth of germline cells.   
      The Drosophila testis has several unique advantages for studying stem cells. First, 
stem cell behavior can be investigated at a single cell resolution, since individual cells 
can be identified and genetically manipulated. In contrast, stem cell markers in 
mammalian systems are more ambiguous, and usually only identify a subpopulation of 
stem cells (1). Second, while the initial establishment of the stem cell niche is largely 
unknown for most vertebrate tissues, major advances have been made recently to 
elucidate the specification of hub cells as well as associated stem cells (35, 36). 
Understanding how a niche is first formed can promote new strategies of tissue 
engineering in regenerative medicine. Lastly, the seemingly simple fly testis share 
similarities with mammalian systems. The general stem cell architecture and steps of 
spermatogenesis are parallel between fly and mouse (37, 38). The recent finding that 
CySCs serve as an additional niche for GSCs, demonstrate the complex but elegant 
regulation in the system, similar to discoveries in mouse bone marrow and bulge of the 
hair follicle (39).  
 
Signaling pathways function in Drosophila testis stem cell-niche system  
      As stated before, the niche provides crucial extrinsic signals to control stem cell 
behavior. The neatly defined testis system and the mature genetic manipulation methods 
in Drosophila have allowed the clear identification of cells either sending or receiving 
signals. The overarching goal of my thesis is to investigate how GSCs are maintained by 
signals emanated from the two distinct niche systems: the hub and CySCs. Therefore, 
below I will describe several signaling pathways identified in the field. Recent advances 
have uncovered the complexity in the testis, especially the importance of BMP signal and 
the niche function of CySCs (40-43). However, we are still at the beginning in 
deciphering cross-regulation among different cell types and relationship of different 
signaling pathways to each other.  
• The JAK-STAT pathway  
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      Two seminal papers identified the JAK-STAT pathway as a key for stem cell 
maintenance in the fly testis (44, 45). The secreted ligand Upd is expressed selectively 
from hub cells. The binding of Upd to its receptor Domeless on adjacent cells activates 
JAK and phosphorylates STAT (Fig.2A). The subsequent translocation of STAT to the 
nucleus activates target gene expression. The requirement of JAK-STAT for stem cell 
self-renewal was demonstrated by generating STAT mutant clones using mitotic 
recombination. STAT null GSCs lose stemness, and leave the hub to differentiate (44, 45). 
Direct target genes of STAT have not been reported. But effectors downstream of JAK-
STAT have been identified in CySCs, and one of them is Zfh1, a zinc finger 
homeodomain transcription factor (to be discussed in more detail below) (42). Cells with 
sustained JAK-STAT activation also have high and sustained expression of Zfh1 (42).  
      JAK-STAT was thought to be required for the self-renewal of both GSCs and CySCs . 
This conclusion came from the fact that testes with STAT depletion in all cells lose both 
stem cell populations (44, 45). However, recent study has further dissected out the 
distinct roles of JAK-STAT on CySCs and GSCs. When STAT activity was restored 
specifically in the cyst lineage of stat mutant testes, functional GSCs were retained even 
though they were depleted for STAT (40). Therefore, JAK-STAT is not intrinsically 
required for GSC self-renewal. The rescued germ cells exhibited all the hallmarks of 
wildtype GSCs, except that they lost contact with the hub (40). Under wildetype 
conditions, E-Cadherin was enriched along the hub-GSC interface; however, E-Cadherin 
was delocalized in STAT-depleted GSCs prior to their loss from the hub (40). Thus, the 
primary role for the JAK-STAT pathway in germ cells regulates GSC anchorage to the 
hub.   
      In contrast to the germ line, CySCs do require JAK-STAT activation for self-renewal. 
CySCs mutated for stat are lost rapidly from the hub (42). JAK-STAT signaling is also 
sufficient to promote CySC fate, as sustained JAK-STAT activity in the cyst lineage 
causes ectopic CySCs (42, 46). Therefore, JAK-STAT plays different roles in the two 
stem cell populations: adhesion for GSCs, and self-renewal for CySCs. It is thought that 
Zfh1 is one downstream target of JAK-STAT, as Zfh1 can phenocopy all the functions of 
JAK-STAT in CySCs (42). However, whether Zfh1 is directly activated by STAT is not 
clear. The activation of JAK-STAT in CySCs is also fine tuned via SOC36E, an 
antagonist of the signaling. When SOC36E is suppressed, CySCs outcompete 
neighboring GSCs through stronger integrin-mediated binding to the hub (47). It has been 
shown recently that the active transcription of SOCS36E in CySCs is maintained by a 
histone demethylase dUTX (48).  
      JAK-STAT signaling also plays a role in dedifferentiation. By growing a temperature 
sensitive allele of stat under the restrictive temperature, Brawley and Matunis created a 
condition in which no stem cells existed (49). However, after shifting these stem cell-
depleted testes to the permissive temperature to allow STAT restoration, stem cells 
reappeared adjacent to the hub (49). It has been shown that the restored stem cells are 
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derived from dedifferentiated spermatogoina (49). Although it is not understood how the 
differentiating cells find their way back to the hub, it is likely that with restored STAT 
activity, the capacity for adhesion to the niche is reestablished among these 
dedifferentiating gonial cells. Note that the study of dedifferentiation has been restricted 
so far to the effects on germline cells for technical reasons. Thus, we know little about 
how somatic cells (that are encysting the germline cells) dedifferentiate into new CySCs. 
• The BMP pathway  
      The evolutionarily conserved BMP pathway is the second pathway identified in the 
field. The BMP ligands dpp and gbb are produced by hub cells and CySCs, and the 
pathway is activated in GSCs (50-52) (Fig.2B). Loss of BMP pathway components in 
GSCs causes premature differentiation (50-52). The direct targets of BMP pathway in 
GSCs are unknown, but Bam, a differentiation factor, is shown to be suppressed by BMP 
activation (50-52). As a consequence of this repression, Bam only becomes expressed in 
daughter cells of GSCs, and Bam function is necessary in these cells for their continued 
differentiation through the gonial amplification into spermatocyte development. 
      For a long time, the importance of BMP was disregarded compared to JAK-STAT. 
However, recent study has shown that BMP is the primary pathway controlling GSC self-
renewal (40). As mentioned before, STAT-depleted GSCs can be retained if JAK-STAT 
signaling is activated normally in the cyst lineage. However, the cell non-autonomous 
effect of the cyst lineage JAK-STAT activation cannot be achieved if BMP activity was 
blocked by misexpressing extracellular BMP antagonist (40). Thus, BMP acts 
downstream of JAK-STAT to guide GSC maintenance.   
• The Hedgehog pathway  
      Hedgehog signaling is another major developmental pathway, and it is also active in 
the testis. Similar to BMP, the requirement of Hedgehog is lineage-specific. Two labs 
have independently shown that the hub-generated ligand Hh is necessary for CySC 
maintenance, as cells mutant for pathway transduction fail to self-renew (46, 53) (Fig.2C). 
Ectopic Hh expression leads to a moderate increase of CySC number, but the extra 
CySCs are confined to the testis tip, and the differentiation in cyst lineage appears normal 
(46, 53). Therefore, sustained Hh promotes CySC proliferation, but not unlimited renewal 
(as STAT activation would). The relationship between Hh and JAK-STAT in CySCs has 
also been investigated. Cells that cannot transduce either Hh or JAK-STAT can still 
activate the other pathway normally (46), thus Hh and JAK-STAT act independently for 
CySC self-renewal, with the STAT pathway playing a more robust role.   
• The EGFR pathway  
      Studies on EGFR signaling have demonstrated cross-talk between the two stem cell 
populations. The ligand Spitz is expressed from the germline cells, and as a consequence 
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the EGFR pathway is activated in the cyst lineage (54-56) (Fig.2D). In testes depleted for 
EGFR receptor function or mutated for Spitz, there are more GSCs present (54-56). By 
staining GSCs with markers for either M- or S-phase mitotsis, Parrot et al. discovered 
that GSCs were dividing more rapidly in spitz mutants (57). For example, when flies 
were fed with food containing DNA analogue BrdU, it took a shorter time for spitz 
mutants to have all GSCs labeled by BrdU (57). Thus, Parrot et al.concluded that GSCs 
in spitz mutants divided faster, causing the increased GSC number. This observation is 
specific to EGFR, as pertubation of other pathways does not result in increased division 
frequency (57). EGFR actiavtion normally occurs in the encysting cyst cells. Thus, the 
inreased proliferation among GSCs was due to something missing from the mutant 
somatic cells. The factor(s) has not been identified, but it might be that direct contact 
from somatic cells is necessary for normal developemnt. The enclosure of germ cells by 
somatic cells also appears abnormal when the EGFR pathway is defective in somatic 
cells. Depending on the mutant conditinon, the germ cells either lack associated cyst cells 
or are surrounded by multiple somatic cells (55, 58). 
      Additonally, the requirement for EGFR activiation in somatic cells further extends to 
transit amplifying spermatognial cells, as these cells continue to proliferate rather than 
undergo differentiation in EGFR mutant testes (54-56).  
• Questions that are going to be addressed in this thesis 
      Taking what we have learned about niche signals for GSC maintenance, two 
important questions need to be addressed. One is about BMP signaling. It is clear that 
BMP is the primary pathway for GSC self-renewal, but we do not know how the signal is 
regulated extracullularly. To address this question, I characterized the role of a novel 
BMP modulator named Magu in the system. The other pressing issue in the field is how 
CySCs, the second niche for GSCs, control GSC behavior. Work from several labs 
including ours has identified four transcription factors (STAT, Zfh1, Chinmo, and Ken) 
that are expressed in CySCs and control GSC self-renewal non-autonomously. 
Understanding effectors downstream of these transcription factors can be breakthroughs 
in elucidating the molecular mechanism of CySC function. However, no target genes of 
any of these transcription factors have been reported. Therefore, I attempted to identify 
targets of Zfh1.   
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Figure 1. The stem cell system in Drosophila testis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 2. Signaling pathways function in 
JAK-STAT (B) BMP (C) Hedgehog (D) EGFR. See text for details. 
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CHAPTER 2 
 
magu is required for germline stem cell self-renewal 
through BMP signaling in the Drosophila testis* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Portions of this chapter were published as: Qi Zheng, Yiwen Wang, Eric Vargas, 
Stephen DiNardo. magu is required for germline stem cell self-renewal through BMP 
signaling in the Drosophila testis. Developmental Biology, 2011. 357 (1): p. 202-10. 
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Summary 
      Understanding how stem cells are maintained in their microenvironment (the niche) is 
vital for their application in regenerative medicine. Studies of Drosophila male germline 
stem cells (GSCs) have served as a paradigm in niche-stem cell biology. It is known that 
the BMP and JAK-STAT pathways are necessary for the maintenance of GSCs in the 
testis (44, 45, 50-52). However, our recent work strongly suggests that BMP signaling is 
the primary pathway leading to GSC self-renewal (40). Here we show that magu controls 
GSC maintenance by modulating the BMP pathway. We found that magu was 
specifically expressed from hub cells, and accumulated at the testis tip. Testes from magu 
mutants exhibited a reduced number of GSCs, yet maintained a normal population of 
somatic stem cells and hub cells. Additionally, BMP pathway activity was reduced, 
whereas JAK-STAT activation was retained in mutant testes. Finally, GSC loss caused by 
the magu mutation could be suppressed by overactivating the BMP pathway in the 
germline. Preliminary data suggests that Magu may modulate BMP signaling through 
interaction with Dlp, a heparan sulfate proteoglycan.  
 
Introduction 
      Adult stem cells contribute a steady source of new cells to maintain many tissues, 
including skin, blood, intestine and the germline. A key hallmark of these cells is their 
ability to generate new stem cells as well as differentiating progeny. Maintaining a 
balance between self-renewal and differentiation is thereby crucial for tissue homeostasis. 
Studies on diverse stem cell systems have demonstrated that the stem cell niche, or the 
local tissue microenvironment, provides important extracellular cues for controlling this 
balance (59). Understanding the modulation of these cues and the signaling pathways 
they act upon is central focus of current research.  
      The Drosophila male germline system has emerged as an exemplary model for 
studying the biology of adult stem cells (60). Cells that comprise the niche have been 
conclusively identified, as have several niche signals that serve to maintain the stem cell 
pool (44-46, 50-53). The apical tip of the testis is occupied by a group of tightly packed, 
terminally differentiated somatic cells, called hub cells (30). Radially arranged around the 
hub are two intermingled sets of stem cells. One is a population of germline stem cells 
(GSCs), and the other is a population of somatic stem cells, called cyst stem cells 
(CySCs).  
      Generally, each GSC division is oriented (32), such that one daughter remains 
adjacent to the hub and to CySCs, thereby retaining stem cell character, while the other is 
pushed away, and will initiate differentiation as a gonialblast (Gb). After four rounds of 
mitosis, the Gb generates a cyst of sixteen spermatogonia, which then undergo 
differentiation into spermatocytes. The division of each CySC is also oriented (34), such 
that one daughter cell remains attached to the hub, and likely retains stem cell identity, 
while the other daughter, displaced away from the hub, becomes a differentiating cyst 
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cell. The cyst cell daughters withdraw from the cell cycle, and they continue to provide 
regulatory input to the encysted differentiating germ cells throughout spermatogenesis 
(61, 62).   
      Both hub cells and CySCs serve as a niche for GSCs (40, 42). It has been shown that 
BMP ligands are expressed from these two types of niche cells, and that they activate the 
BMP pathway in GSCs (50, 52). One output of pathway activation is repression of bag of 
marbles (bam) in GSCs, which would otherwise drive differentiation (50-52). Loss of 
BMP receptors or signal transducers in the GSCs causes de-repression of bam and 
precocious differentiation (50-52). Recently, Michel et al. develops a fluorescent reporter 
for the activation of BMP type I receptor Thickvein (63). Using this tool, they have 
demonstrated that BMP signals from the hub are specifically received at the hub-GSC 
interface, where adherens junctions locate (63).  
      The second signaling pathway active in the stem cell niche is the JAK-STAT pathway. 
Unlike BMPs, Unpaired (Upd), the JAK-STAT ligand, is only expressed from hub cells 
(44, 45). Upd activates the pathway not only in GSCs, but also in CySCs (40, 42, 44, 45). 
JAK-STAT activation appears important for adhesion of both GSCs and CySCs to the 
hub, but is only crucial for self-renewal of the CySCs (40, 42).   
      Although BMP signaling is required for GSC maintenance, research has heavily 
focused on JAK-STAT in stem cell self-renewal over the last several years. Part of the 
reason may be because induction of ectopic GSCs can be achieved by overactivating the 
JAK-STAT pathway, but not the BMP pathway (44, 45, 50-52). However, recent work 
from our lab demonstrates that the expansion of GSCs is not directly due to activation of 
JAK-STAT in GSCs, but rather due to JAK-STAT activation in CySCs, and the 
consequent enhanced expression of BMP ligands from CySCs (40). Therefore, it now 
appears that BMP is the primary pathway leading to GSC self-renewal, and it is 
imperative to dissect out the mechanism by which BMP signaling maintains GSCs.  
      In a previous microarray experiment performed by our lab, CG2264 was identified as 
a gene exhibiting transcriptional enrichment in cells near the testis tip (64). Subsequently, 
Li and Tower reported that global ectopic expression of CG2264, which they named 
magu, led to an increased life span in both sexes and an increase in the fecundity of older 
females (65). Vuilleumier et al. have also identified CG2264, naming it pentagone (pent), 
and demonstrated, through loss- and gain-of-function experiments, that it was required 
for the proper graded activation of the BMP pathway during wing patterning (66). 
Interestingly, the Xenopus homologue of CG2264 has been shown to block BMP 
signaling during early dorso-ventral patterning of embryos (67).  
      Here, we will use magu as the name for CG2264. We report that magu is expressed 
from hub cells, and functions as a BMP modulator that specifically affects the GSC 
population. Our work emphasizes the importance of BMP signaling in male GSC 
maintenance.  
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Results 
magu is expressed from hub cells  
      Using in situ hybridization, we visualized magu mRNA in the hub cells (Fig.1A). In 
our hands, in situ hybridization in testes did not have the resolution and reproducibility 
usually afforded in other tissues. We always observed signals among small cells clustered 
at tip (Fig.1A, arrowheads), and we concluded that these were hub cells. Due to the 
technical limitations, we could not rule out the possibility that magu is expressed in some 
somatic cells near the hub (in some CySCs). However, we have not observed any 
evidence of expression in large-profile cells surrounding the hub. Thus, we are confident 
that magu is not expressed in germline cells. Interestingly, in situ hybridization 
sometimes suggested that magu was expressed only from some hub cells, or to higher 
degree from some hub cells (Fig.1A, arrowheads).   
      To more definitively identify which cells express magu, we made use of a LacZ 
reporter line of magu (66). This reporter utilizes a 2 kilobase fragment that recapitulates 
magu expression in the developing wing disc (66). In the testis, we observed that magu 
expression was restricted to hub cells as shown by double-labeling with E-Cadherin 
(Fig.1B). Interestingly, the reporter was not expressed in all hub cells. It remains possible 
that some other regulatory region at magu drives expression in the remaining hub cells. 
However, since some of our in situ preparations also suggested non-homogenous 
expression from hub cells, perhaps magu is under temporal or spatial control, and under 
repression by BMP signaling (66). Indeed, mutation of Mad/Medea/Schnurri binding 
sites within the reporter fragment led to expression in most hub cells (Fig.1C). 
Collectively, our data suggest strongly that magu is expressed from hub cells, but 
potentially not from all hub cells equally.   
      magu encodes a putative matricellular protein, which is defined as a secreted protein 
that could regulate cell-matrix interactions. To investigate the localization of Magu, we 
raised antibodies against an N-terminal portion of Magu (Yiwen Wang). Sera from 
immunized rabbits showed specific immuno-reactivity on western blots to bacterially 
expressed, His-tagged Magu protein (Yiwen Wang, data not shown). After preabsorption 
using wildtype testes (see Materials and Methods), we observed an enriched pattern of 
puncta in the hub region (Fig.1D, D’). Magu accumulated along the interfaces among hub 
cells (Fig.1D upper inset), similar to FascIII. In addition, it was present along the 
interface between hub cells and stem cells (Fig.1D lower inset, arrowheads). Since this 
serum was effective only sporadically, we also explored the accumulation of Magu by 
using a second antibody, raised against a C-terminal peptide (66). This antiserum 
reproducibly exhibited an extended distribution of Magu relative to the hub, with strongly 
staining puncta appearing among stem cells and their daughters (Fig.1E, and insets; E’, 
bracket). In addition, there was a more subtle enrichment in a ring along the hub cell-
stem cell interface (Fig.1E lower inset and E’, arrowhead), reminiscent of that obtained 
with the N-terminal antisera. These patterns were reduced significantly in testes bearing 
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mutations in magu (Fig.1F, F’).  Since Magu is predicted to be a secreted protein, we 
attempted to visualize Magu under conditions where the antibody could only detect 
extracellular proteins (see Materials and Methods). Using the C-terminal antiserum (but 
not the N-terminal antiserum) a strong punctuate signal was observed only in optical 
sections above the hub (Fig. 1G), and this pattern disappeared in the magu mutant 
(Fig.1H). We do not know if the differences in accumulation pattern comparing the two 
antisera reflect differing distributions or availabilities of their respective epitopes. 
Nevertheless, these data are consistent with the model whereby magu is transcribed in 
hub cells, and its encoded protein secreted and accumulates in the vicinity of neighboring 
cells.  
Generating magu mutants   
      In order to investigate the function of magu, we identified mutations among 
transposon insertion lines and generated null mutations by manipulating those lines (see 
Materials and Methods). Two insertions, KG02847b (KG) and d00269, were 
homozygous viable and exhibited no detectable phenotype. These insertions were 
mapped upstream of exon 3 of magu (Fig.2A). However, flies homozygous for the 
insertion e00439, or heteroallelic combinations of e00439 and f02256 were viable and 
exhibited both a wing vein defect (Fig3.B, C) and a testis phenotype. These PiggyBac 
insertions each mapped near the 3’ end of exon 3 (Fig.2). To obtain potentially stronger 
mutant alleles, we generated deletions encompassing some or all of the genomic region 
containing magu (Yiwen Wang). Deletion mutant I lacked exon 3, which contained the 
magu translational start codon (Fig.2). More extensive deletions were generated from the 
KG insertion. Individual deletions removed the whole magu region downstream of KG, 
and extended from 15 to 374 kilobases downstream of magu (Fig.2). By comparing the 
strength of both the wing vein and testis phenotypes, we established that e00439 and 
deletion I behave as null alleles of magu, while f02256 is a strong loss-of-function allele.    
      Below I will first characterize the testis phenotype, and then touch on the wing vein 
defect in the later part of the Results section.  
 
Magu is required for maintenance of GSCs  
      Compared with wildtype, magu mutant testes appeared thinner, containing fewer 
germ cells (data not shown). Since magu was expressed from hub cells, we tested 
whether a GSC defect might account for this phenotype. We scored GSCs by counting 
individual small-size germ cells attached to the hub. In one mutant condition, 
mague00439/maguf02256, the median GSC number per testis was only 3, whereas the sibling 
control carried a median of 9 GSCs (Fig.4A, B; Table 1). Moreover, magu mutant testes 
displayed germ cells with branched fusomes next to the hub (Fig.4D arrowhead), 
indicating they were differentiated and no longer bona fide stem cells. We found a 
similarly dramatic reduction in the median number of GSCs for other magu mutant 
combinations (Table 1). We also noticed that there was variation in phenotypic strength. 
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For a given allele, or allele combination, some mutant testes were devoid of all GSCs, 
while others retained some GSCs. As a measure of this, we also calculated the percentage 
of testes with GSCs for each genotype. That fraction depended on the genotype and 
growth condition used in a particular experiment (Table 1).  
      We took two approaches to confirm that the defect in GSC maintenance indeed 
resulted from mutation of magu. First, the transposon insertion, e00439, was remobilized 
to establish a revertant line (Yiwen Wang). We found that GSCs were substantially 
restored in flies carrying this revertant chromosome placed over the f02256 mutant 
(Table 1). While there remained a slight difference in the median number of GSCs 
retained in the revertants compared to controls, all revertant testes now retained GSCs. 
Second, we attempted to rescue the GSC defect by restoring magu expression in the 
mutant background. To accomplish this, we used the hub cell driver upd-Gal4 to express 
magu containing either an N-terminal (V5) (66) or C-terminal (Myc) epitope tag. To 
promote continued and robust expression using the Gal4-UAS system, young adults were 
aged at 29oC for either 3 days or 12 days before analysis. We scored both median GSC 
number, and the fraction of testes maintaining GSCs. Using both measures, we obtained 
statistically significant, but incomplete rescue. Among mutant siblings from these crosses, 
it was common that more than half of the testes contained no GSCs. When either N-
terminal V5- or C-terminal Myc-tagged magu was expressed in the mutants, the fraction 
of testes with GSCs increased to more than 50%, and sometimes approached or equaled 
100% (Table 1) Restoration of V5-magu also increased the median number of GSCs for 
both younger and older flies (Fig.4E; Table 1). But restoration of magu-Myc only led to 
an increase in median GSC number for older flies (Table 1). This was the case using 
several different UAS-magu-Myc or GFP transgenic insertion lines (data not shown). 
Thus, the slightly different behavior of N-terminal versus C-terminal rescuing construct 
might be due to a difference in inherent activity of the proteins produced. We observed a 
similar difference in rescuing ability for the wing vein defect of magu mutants (Fig.3D, 
E). In spite of the difference in transgene effectiveness, collectively, the data demonstrate 
that Magu is required for normal GSC number in the adult testis.  
      The loss of GSCs was also observed in magu mutant gonads from the 3rd instar 
larvae (Table 1). But the phenotype in gonads was much less severe than in adult testes, 
because the median GSC number per mutant gonad was much higher, and all mutant 
gonads still retained some GSCs (Table 1). This suggested that Magu plays a dominant 
role in adult GSC maintenance. To test this hypothesis, we conducted a so-called cohort 
experiment, in which GSC numbers were counted in magu mutants at different 
developmental stages. Animals dissected at a later stage were siblings of those processed 
earlier. We hoped to minimize any phenotype variation by conducting the experiment in 
this controlled way. We found that GSC number was normal in 1st instar larvae gonads of 
magu mutants, but progressively reduced in 3rd instar larvae gonads and testes (Table 2). 
This demonstrated that Magu does not affect GSC establishment, even though it was 
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expressed in embryonic gonads (data not shown). It also confirmed that Magu functions 
during larva development, and it is possible that the more severe phenotype observed in 
mutant testes is an accumulation effect due to continuous loss of Magu since an earlier 
stage.  
      To further dissect out from which larva stage Magu starts to play a role in GSC 
maintenance, we designed an experiment called larva shift experiment. We wanted to 
compare the rescue extent in magu mutants, for which ectopic Magu expression was 
turned on at different time points during larvae development. We hypothesized that if the 
function of Magu begins right after GSC specification, then mutant cohorts with Magu 
activation started earlier would have a higher GSC number compared to those started 
later. To achieve this, magu mutants were initially grown at 25°C. One cohort containing 
1st and 2nd instar larvae (early shift), and another cohort with 3rd instar larvae and early 
pupae (late shift), were moved to 29°C to allow the maximum expression of ectopic 
Magu by Gal4-UAS system. Eclosed young adult flies were further aged at 29°C for 3 
more days before analysis. It turned out that the rescue efficiency was not statistically 
different in the two cohorts (Table 3). This suggested that Magu may not function until 
the late stage of larval development. However, there was a caveat for this conclusion. 
Since the GSC number in sibling control testes was also lower than normal (Table 3), we 
suspected that the presence of the transgene upd-Gal4 could result in GSC reduction at 
29°C for unknown reason (we also noticed this in magu RNAi experiments, data not 
shown). This may add a complexity to the larva shift experiment, as the longer animals 
with upd-Gal4 were aged at 29°C, the more likely their GSC numbers would get reduced.       
  
Magu does not affect CySC or hub cell number  
      In the normal testis, GSC self-renewal depends on CySCs and hub cells (40, 42). 
Thus the loss of GSCs that we observed in magu mutant testes could be a secondary 
effect attributed to either CySCs or hub cells. To determine whether there are any defects 
among CySCs in the magu mutants, we analyzed the number of CySCs by staining for 
Zfh1, an essential CySC marker (42). In contrast to the GSCs, significant numbers of 
Zfh1-expressing cells were still present in the mutant (Fig.5B; Table 4). These cells were 
arranged more compactly around the hub, presumably because they now occupied the 
space vacated by the loss of GSCs (Fig.5A, B). To investigate whether CySCs in the 
mutants function properly, we marked cycling cells by S phase labeling using Edu. The 
ratio of Edu and Zfh1 double positive cell number to Zfh1 single positive cell number in 
the mutants was indistinguishable from that in the sibling controls (Fig.5C, D arrowhead; 
Table 4), indicating that the mutant CySCs cycle properly. To further confirm the 
undifferentiated state of CySCs in mutant testes, we examined Eya expression as a 
marker for cyst cell differentiation (Fig.6). The small-sized cyst cells close to hub did not 
express Eya (Fig.6B, B’). We occasionally noted some Eya positive cyst cells near the 
hub in magu mutants (Fig.6C arrowhead, C’). But these cells were much larger, 
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suggesting they were late-stage cyst cells, associated with spermatocytes, that had failed 
to be pushed away from the hub due to the reduced production of germ cells. Thus, taken 
together with their expression of Zfh1 and cell cycling behavior, we conclude that these 
cells were bona fide CySCs.   
      To test whether Magu affects the maintenance of the hub, we counted hub cell 
numbers using the cell biological hub marker FascIII (Fig.5E, F). We found magu 
mutants contained a similar number of hub cells compared to sibling controls (Table 4). 
To determine whether these hub cells were capable of functioning properly, we asked 
whether they expressed a key niche signal, upd. Indeed, upd was expressed normally in 
magu mutant testes, and there was no difference in the number of upd positive hub cells 
comparing mutants and sibling controls (Fig.5G, H; Table 4). Thus we conclude that the 
loss of GSCs in magu mutants is not secondary to depletion or defect of either of the 
essential niche cell types, the CySCs or hub cells.   
 
What pathways might Magu use to control GSC maintenance?  
      At the time of this work, the major signaling network in the establishment and 
maintenance of GSCs involved the JAK-STAT pathway (44, 45, 68). As shown in Fig.4H, 
magu mutants did not affect the expression of Upd, a key JAK/STAT-activating ligand 
expressed from hub cells. To test whether magu mutants affect activation of the STAT 
pathway, we analyzed the accumulation of STAT protein. In control testes, STAT 
accumulated among the first tier of cells surrounding the hub (Fig.7A). This represented 
STAT accumulation in both nearby germ cells and somatic cells (the GSCs and CySCs). 
In magu mutants, which have a normal complement of CySCs and occasionally have 
some remaining GSCs, STAT accumulated in cells surrounding the hub in a similar 
pattern to wildtype (Fig.7B). Therefore Magu does not appear to affect STAT pathway 
activation.   
      Once we ruled out involvement in JAK-STAT signaling, we sought clues for Magu 
function by further analyzing its role during wing patterning.  
 
Magu also affects the specification of the 5th longitudinal wing vein L5  
      The wing vein defect in magu mutants was predominantly a failure in the patterning 
of L5, the 5th longitudinal wing vein (Fig.3B, C, arrowhead). Since so much is known 
about the patterning of wing veins, we thought clues for the function of Magu in testes 
might come from also investigating its role in vein development.  
      The development of Drosophila wing veins starts on wing imaginal discs during 
larval stages. The primordial longitudinal veins (L1 to L5) are already specified and 
identifiable on the 3rd instar larval wing blade (Fig.8A, copied from Fig.1A Blair 2007). 
To investigate whether magu is expressed during wing vein specification, we performed 
an in situ hybridization experiment. The expression of magu was mainly visualized in 
peripheral cells on wing blade, including regions around L5 (Fig.8B, arrow). magu 
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expression also appeared in the notum region of the wing disc (Fig.8B, arrowhead). To 
further test whether Magu affects the specification of L5, we examined the vein 
patterning on magu mutant wing discs. Delta is a marker for three longitudinal veins L3 
to L5, whereas DSRF marks all intervein cells. For sibling control wing discs, L5 was 
scorable in all 9 samples by Delta staining (Fig.8C, arrow), and 7 out of 11 samples by 
DSRF (Fig.8D, arrow). In contrast, we observed that L5 could only be unambiguously 
identified in about 3 out of 20 magu mutant discs by either Delta or DSRF staining 
(Fig.8D, F, arrow). Therefore, we concluded that Magu affected the specification of L5.  
      It has been shown that the BMP signaling pathway is required for L5 specification. 
Interestingly, the mutant phenotype of the BMP ligand gbb resembles that seen in magu 
mutants (69-71). Thus we hypothesized that Magu also affects BMP signals in the wing. 
The most straight-forward way to test this hypothesis was to examine BMP activation on 
magu mutant discs. However, we had difficulty achieving high enough signal-to-noise 
pMad staining on wildtype discs initially.  Therefore, we decided to test the expression of 
Abrupt, a L5 organizer that functions downstream of BMP activation (72). In sibling 
control testes, the staining of Abrupt nicely marked L5 (Fig.8G, arrow), in a pattern 
sharply complementary to that of DSRF (data not shown). However, in magu mutant 
discs, the staining of Abrupt was less clear (Fig.8H, arrow), showing an overlap with 
DSRF (data not shown). This result supported the idea that Magu might affect BMP 
pathway in L5 patterning.  
      We were interested to know whether Magu plays a role on the BMP signal-sending or 
receiving side. To investigate this, we induced magu mutant clones in heterozygous wing 
discs. The idea was that if Magu functions on the signal-receiving side and acts only 
locally, a defect in L5 region would be observed when the mutant clones cover the 
responding cells. While we could successfully generate magu mutant clones, we could 
not detect L5 defect by either DSRF or Abrupt staining (data not shown). This is 
consistent with the fact that Magu is predicted to be a secreted protein. Surrounding 
wildtype cells would supply Magu to the mutants. 
      We aborted our further analysis of wing patterning with publication of the 
Vuilleumier et al. paper in which the role of Magu in wing vein patterning was 
characterized nicely. They showed that Magu is necessary for proper transport of the 
BMP ligands; without Magu, BMPs cannot properly reach the disk region for L5 
specification (see Discussion). 
 
Magu affects GSC maintenance through the BMP signaling pathway 
      Our preliminary data on wing vein patterning suggested that Magu may be involved 
in BMP signaling. In fact, the BMP pathway has been shown to that is required for GSC 
maintenance is BMP (40, 50-52). To test whether Magu affects this pathway, we 
examined the activation of Mad, a transducer of BMP signaling. In several tissues, the 
accumulation of phosphorylated Mad (pMad) can be used as a read-out of BMP pathway 
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activation. We never observed pMad staining among germ cells surrounding the hub in 
magu mutant testes (Fig.7D). However, we could not conclude that BMP pathway 
activation was compromised because we found it difficult to observe pMad staining 
consistently in the GSCs of control and wildtype testes. In our hands, only occasionally 
would control testes present with pMad accumulation among the tier of germ cells 
surrounding the hub (Fig.7C). In contrast to that inconsistency in testes, gonads from 3rd 
instar larvae reproducibly showed pMad staining (Fig.7E). In gonads from magu mutants, 
we never observed pMad accumulation in germ cells surrounding the hub (Fig.7F), 
suggesting strongly that BMP pathway activation was compromised in magu mutants. In 
passing, we noted two characteristics of pMad accumulation in control larval gonads. 
First, in some gonads, not all the GSCs were positive (data not shown). Second, we often 
observed pMad accumulation in the second tier germ cells (Fig.7E, arrowheads), likely 
gonialblast progeny of the GSCs. This suggests occasional, more broad BMP pathway 
activation than previously reported. 
      To confirm the apparent diminution of BMP signaling in magu mutants, we examined 
a presumed target of BMP activation, the bam gene, whose expression is repressed in 
BMP-signaled cells. We used a bam promoter-GFP transgene (bam-GFP) (73) as a read-
out for pMad activity. Consistent with a defect in BMP activation in magu mutants, bam-
GFP was enriched in some germ cells attached to the hub (Fig.7H, arrowhead), while it 
was expressed only in amplifying gonial cells in control testes (Fig.7G). This data 
supports the hypothesis that Magu affects BMP signaling.  
      To further demonstrate the involvement of Magu in BMP signaling pathway, we 
conducted a genetic interaction experiment to test whether transheterozygotes of magu 
and gbb would have a reduced number of GSC. Gbb is a BMP ligand in Drosophila. It 
has been shown that Gbb plays an essential role for male GSC maintenance in testes, and 
gbb1 is a null allele of gbb. As shown in Table 5, the reduction in GSCs was observed in 
younger flies of maguf02256/+; gbb1/+, as well as older flies of mague00439/+; gbb1/+.   
      If magu was indeed required for proper BMP activation in germ cells, constitutive 
activation of the BMP pathway in the germline could bypass the requirement for magu. 
To accomplish this, we expressed an activated form of BMP type I receptor Thickvein 
(TkvA) using the germ cell driver, nanos-Gal4:VP16. Indeed, this raised the fraction of 
testes with GSCs from 63% to 100% (Table 1). The median GSC number also doubled 
compared to that observed in mutants (Fig.7J; Table 1). Thus intrinsic activation of the 
BMP pathway in germ cells can bypass the need for magu. This result is consistent with a 
simple model that GSCs are lost because BMP activation is compromised in magu 
mutants.   
      magu encodes a secreted protein, expressed selectively from hub cells, and 
accumulating among cells nearby. Our data suggests that Magu is necessary for proper 
BMP activation within adjacent germ cells.  BMP ligands appear to be produced by both 
hub cells and CySCs, but not by germ cells (50, 52). To test whether magu must be co-
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expressed with BMP ligands for its proper function, we attempted to rescue the GSC 
defect using the germ cell driver nanos-Gal4:VP16. Indeed, we observed a statistically 
significant increase in median GSC number in such testes (Fig.4F; Table 1). This 
suggests that magu does not need to be co-expressed with BMP ligands to be effective, 
and likely acts in the extracellular environment. 
 
Magu may interact with Dlp in testes  
      Vuilleumier et al. also suggested that Magu interacts directly with Dally, a HSPG 
(heparan sulfate proteoglycan) (66). Interestingly, Dally and its homologue Dally-like 
(Dlp) are also important for male GSC maintenance (74, 75). Furthermore, it had been 
reported that Dlp was specifically expressed in hub cells, consistent with a major role for 
GSC maintenance ((75), Fig.9E, E’). I undertook extensive effort to verify the expression 
pattern of Dlp. I never observed selective accumulation of Dlp among hub cells. For 
example, Dlp appeared at low levels among all cells at the tip of the testes (Fig.9A, B), 
and not restricted to hub cells (Fig.9A’, B’; white). I even stained fruit fly testes from 
different genetic backgrounds, including the one used in the Hayashi et al. paper (Oregon 
R, Fig.9B, B’). We communicated these (negative) observations to the authors, and they, 
too, cannot confirm their published description.  
      While expression enrichment was not observed, the previous authors’ genetic analysis 
still stood. Since dlp and dally were required for GSC maintenance, we took two 
approaches to test the possible interaction of Magu and HSPG in testes. The first 
involved genetic interaction experiments between magu and dally, dlp or two other genes 
needed for HSPG biosynthesis. However, we did not observe any difference in GSC 
numbers between heterozygous magu mutants and transheterozygotes of magu and HSPG 
mutants (Table 6).   
      The other attempt was to rescue magu mutants by overexpressing Dlp. When ectopic 
Dlp was expressed in germ cells using nanos-Gal4 UAS-dlp-GFP, the fraction of testes 
retaining GSCs among magu mutants was indeed increased (Table 7). However, the 
expression pattern of ectopic Dlp appeared different in control and mutant. Dlp-GFP 
accumulation as visualized by GFP staining was enriched only at the hub cell-GSC 
interface in sibling control testes (Fig.10A’, arrow). In contrast, Dlp protein appeared 
more diffused in magu mutant testes, in a punctate distribution, and often surrounding 
GSCs (Fig.10B’, arrow). This suggested that the location of Dlp is Magu-dependent.  
      Since Magu was expressed from hub cells, to further confirm the diffused location of 
Dlp in magu mutant, we overexpressed dlp-GFP from hub cells using hh-Gal4. Because 
Magu was an extracellular protein, we also chose to examine extracellular Dlp proteins 
by staining non-permeabilized testes. In sibling control testes, Dlp was mainly enriched 
along hub-GSC interfaces (Fig.11A’, arrow). In magu mutant testes, the accumulation of 
Dlp was not restricted to the hub-GSC interface, but also accumulated among hub cells 
(Fig.11B’, arrow). Interestingly, in some mutant testes, the extracellular Dlp staining 
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extended beyond hub cells, and appeared to embrace somatic cells next to the hub 
(Fig.11C, arrow). Since there was no extracellular Magu protein present in the mutants 
(Fig.1H), these results suggest that extracellular Magu may be functional in the testis, 
regulating the localization of secreted Dlp.   
 
Magu may not interact with Perlecan, Type IV Collagen, and Integrin  
      Because Magu was predicted to be a matricellular protein, we wanted to know 
whether Magu could interact with other extracellular matrix (ECM) proteins. To visualize 
the ECM, we stained testes using antibodies against either Perlecan or Type IV Collagen, 
two major components of basal lamina. We observed that both proteins accumulated 
under the sheath of testes (Fig.12A, C). Occasionally, they also exhibited as a hazy 
staining or two layers at the tip of testes (Fig.12A, C, arrow). This was expected, as EM 
micrographs have shown that the hub is anchored to the tip through a convoluted layer of 
basal lamina (Hardy, 1979).  In most magu mutant testes, we did not observe a defect of 
basal lamina (data not shown). But sometimes, the Perlecan staining appeared thicker in 
mutants. In the most severe case, the sheath of testes seemed delaminated, and the ECM 
arced further into the testes (Fig.12B, arrow). We did not think this phenotype was a 
primary defect in magu mutants. The protruding ECM could be layers of muscle and 
pigment cells from the sheath of testes. These layers were usually as prominent in 
wildtype testes, as they were tightly pressed to each other with basal lamina by the 
plentiful cells inside testes. Since magu mutants had fewer germ cells, the testes might 
not be stretched as much, thus the different layers of the sheath became more 
distinguishable. To further test the possible interaction of Magu and ECM proteins, we 
co-stained extracellular Magu and Type IV Collagen in wildtype testes, but did not 
observe an overlap (Fig.12D). Thus we concluded that Magu does not interact with basal 
lamina proteins.  
      Another possible role of an ECM protein is that it regulates signal transduction 
pathways through interactions with cell-surface receptors like Integrin. To test this 
possibility for Magu, we examined the location of βPS-Integrin in sibling control and 
magu mutant testes. The staining appeared in somatic cells in both genotypes (Fig. 12E, 
E’). Since Magu specifically affects GSC maintenance, we concluded it unlikely that 
Magu acts through Integrin.  
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Figure 1. magu is expressed from hub cells. The genotype for WT is w1118, for magu/+ 
is magudeletionI/CyOKrGFP, and for mutant is magudeletionI/magudeletionI. Hub (E-Cadherin 
in B and C, FascIII in other panels, white); germ cells (Vasa, green). (A) In situ 
hybridization revealing magu RNA in hub cells. RNA was enriched toward the portion of 
hub cells that faces the stem cell tier (arrowheads). (B and C) The lacZ expression (LacZ, 
red) in flies transgenic for magu reporter line frgII-lacZ (66) revealed the expression of 
magu in a few hub cells (B), whereas expression driven by a mutated version of frgII-
lacZ (frgII∆S-lacZ) (66) was expanded into almost all hub cells (C). This suggests that 
BMP pathway is active in these cells. The expression in spermatogonia far away from the 
testis tip in C was spurious. (D and D’) magu protein exhibited an accumulation in the 
hub region, as visualized by anti-Magu-N-term (D and D’, red). The expression was not 
only in the interface between hub cells (D upper inset), but also presented along the hub 
cell-germ cell interface (D lower inset, arrowheads). (E-F’) Using another antibody (anti-
Magu-C-term, (66)), Magu accumulated in a broader domain around the hub (E upper 
inset, and E’ red inside the bracket). The expression appeared to be a circle along the 
interface of hub cell and germ cells (E lower inset and E’, arrowheads). The accumulation 
was highly reduced in magu mutant testes (F, and F’ red inside the bracket). The signal 
also presented in late stage spermatogonia and cyst cells in both sibling control and magu 
mutant testes (data not shown). Thus it must be due to cross-reaction with non-Magu 
epitopes. (G and H) The extracellular Magu, visualized by applying anti-Magu-C-term 
(66) prior to fixation, exhibited an enriched punctate pattern in areas near the hub (G, red). 
This dotted staining disappeared in the magu mutant (H).  
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Figure 2. magu gene structure and mutants. The map of magu is shown in blue with 
exons denoted by rectangles, and genes downstream of magu are represented in green. 
Positions of transposable elements used to create deletion mutants are denoted by red 
triangles. The deleted sequences are indicated by dashed lines. Deletion I lacks the 
sequence between the PiggyBac insertions d00269 and f02256, which contains exon 3 
and the translational start codon. Extent of deletions in KG deletion line begins from 
KG02847b to at least 15 kilobases downstream of magu. 
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Figure 3. magu mutants also exhibit wing phenotypes. The genotype for mutant is 
mague00439/maguf02256. (A-C) Compared with w1118 (A, arrow and arrowhead), the magu 
mutants exhibited a truncated 5th longitudinal vein (B and C, arrowhead), and loss of 
posterior crossvein (B). The wing size was also reduced in magu mutants (C). (D and E) 
The wing vein defects were restored when Magu was ectopically expressed in the dorsal 
domain of wing discs. The genotypes were mague00439/maguf02256ap-Gal4;UAS-Magu-
Myc(D), and mague00439/maguf02256ap-Gal4;UAS-V5-Magu (E). Notice overexpressing 
V5-Magu also caused some gain-of-function phenotypes, for instance the excess veins (E, 
arrowheads), indicating this transgene is stronger than UAS-Magu-MyC. 
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Figure 4. GSCs are lost in magu mutants. The genotype for magu/+ is mague00439 or 
maguf02256/ CyOkr-Gal4UAS-GFP, and for mutant is mague00439/maguf02256. Hub (FascIII 
or asterisk, white); germ cells (Vasa, green); fusome (α-Spectrin, red). (A and B) A 
control testis tip exhibited five GSCs attached to the hub (A, arrowheads), while the tip of 
a magu mutant testis carried one remaining GSC (B, arrowhead). (C and D) The dotted 
fusome, unique to GSCs, was present in an individual germ cell adjacent to the hub in a 
magu/+ testis (C, arrowhead), whereas branched fusomes, a character of differentiated 
cells, were located in a cyst of germ cells directly contacted to the hub in a magu mutant 
(D, arrowhead). (E and F) Overexpression of Magu in either hub cells (E) or germline (F) 
resulted in ectopic GSCs next to the hub in the mutants. 
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Table 1. magu affects GSC maintenance  
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - Max c P value d 
 
% of 
Testes 
w/GSCs 
P value e   
 
0-3 days, 25oC 
(unless noted)  
magu[e] or [f] /CyO f  8 (19) g 8 - 10 6 -13  100  
magu[e] /magu[f]  3 (21) 2 - 4 0 - 7 <0.01 76 NA h 
magu[e] or [delI] /CyO 7 (10) 7 - 7.8 6 - 9  100  
magu[e] /magu[delI] 0 (10) 0 -1.5 0 - 6 <0.01 30 NA 
magu[KG delI] or [f] /CyO 10 (10) 9.3 - 11 8 - 12  100  
magu[KG delI] /magu[f]   2.5 (10) 0 - 4 0 - 5 <0.01 60 NA 
magu[delI] /CyO i  9 (13) 7 - 10 6 - 13  100  
magu[delI] / magu[delI] i 6 (10) 5.3 - 7.8 4 - 9 <0.01 100 NA 
magu[eREV] or [f] /CyO 9 (8) 8 - 9 5 - 10  100  
magu[eREV] /magu[f]   7 (10) 6 - 8 4 - 9 <0.05 100 NA 
aged at 29oC 
for 3 days j  
upd-Gal4; magu[e] /magu[f] ; 
MKRS 
 
0 (23) 
 
0 - 3.5 
 
0 - 6  
 
43  
upd-Gal4; magu[e] /magu[f] ; 
UAS-V5-magu 
 
4 (21) 
 
3 - 5 
 
1 - 7 
 
<0.01 
 
100 
 
<0.01 
upd-Gal4; magu[e] /magu[f] ; 
MKRS 
 
0 (27) 
 
0 - 3 
 
0 - 6  
 
44  
upd-Gal4; magu[e] /magu[f] ; 
UAS-magu-Myc 
 
3 (25) 
 
0 - 4 
 
0 - 8 
 
>0.1 
 
64 
 
<0.01 
aged at 29oC 
for 12 days j 
upd-Gal4; magu[e] /magu[f] ; 
MKRS 
 
0 (12) 
 
0 - 0.3 
 
0 - 3  
 
25  
upd-Gal4; magu[e] /magu[f] ; 
UAS-V5-magu 
 
4 (12) 
 
2.8 - 4 
 
2 - 5 
 
<0.01 
 
100 
 
<0.05 
upd-Gal4; magu[e] /magu[f] ; 
MKRS 
 
0 (11) 
 
0 - 0 
 
0 - 0  
 
0  
upd-Gal4; magu[e] /magu[f] ; 
UAS-magu-Myc 
 
3 (17) 
 
2 - 4 
 
0 - 5 
 
<0.01 
 
94 
 
NA 
0-5 days, 25oC magu[e] /magu[f] ; MKRS 3 (18) 2 - 4 0 - 6  83  
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magu[e] /magu[f] ; nanos-
Gal4/UAS-magu-Myc  
 
4 (15) 
 
3 - 5 
 
2 - 7 
 
<0.05 
 
100 
 
>0.05 
magu[e] /magu[f] ; MKRS 2 (13) 0 - 4 0 - 5  62  
magu[e] /magu[f] ; nanos-
Gal4/UAS-magu-GFP 
 
4 (17) 
 
3 - 4 
 
2 - 6 
 
<0.05 
 
100 
 
<0.01 
0-3 days, 25oC magu[e] /magu[f] ; MKRS 2.5 (16) 0 - 4 0 - 6  63  
magu[e] /magu[f] ; nanos-
Gal4/UAS-tkvA 
 
5 (25) 
 
3 - 6 
 
1 - 8 
 
<0.01 100 
 
<0.01 
a Alleles used: [e]=[e00439]; [f]=[f02256]; [eREV]= [revertant of e]; [del I]=[deletionI]; [KG del]=[KG deletion].  
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th percentile, Q[1] = the 25th percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e Calculated by Chi-square test. 
f CyOkr-Gal4UAS-GFP 
g
 Number of testes scored in parentheses 
h
 Not Applicable  
i GSC number scored in gonads from 3rd instar larvae. 
j
 Animals (0-3 days of age) raised at 25oC were shifted to 29oC for 3 or 12 days. 
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Table 2. Cohort Experiment 
 
Condition Genotype a 
 
Median GSC #  
 
 
IQR b 
 
Min - Max c P value d 
 
1st instar larvae  magu[delI] / CyOGFP 7 (11) e 6 - 9 5 - 9  
magu[delI] / magu[delI]  7 (17) 6 - 8 5 - 9 >0.05 
3rd instar larvae  magu[delI] / CyOGFP 12.5 (6) 11.3 - 13 10 - 13  
 magu[delI] / magu[delI]  6 (12) 5 - 7 5 - 8 <0.01 
0-6 days adult flies  magu[delI] / CyOGFP 11 (15)  10 – 11.5 9 - 12  
magu[delI] / magu[delI]  0 (17) 0 - 0 0 - 8 <0.01 
a Allele used: [del I]=[deletionI]. 
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th percentile, Q[1] = the 25th 
percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e
 Number of testes scored in parentheses 
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Table 3. Larva Shift Experiment 
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - Max c P value d 
 
 
P value e 
 
early shiftg upd-Gal4; magu[e] /magu[f]; MKRS  2 (7) f 1.5 - 2.5 0 - 5   
 
 
 
 
0.46 
upd-Gal4; magu[e] /magu[f]; UAS-V5-magu 4 (12) 2.3 - 5 2 - 6 <0.05 
upd-Gal4; magu[e] or [f]/CyO; MKRS 4 (8) 0 - 4 0 - 5  
upd-Gal4; magu[e] or [f] /CyO; UAS-V5-magu 5.5 (10) 5 - 7 4 - 8 <0.01 
late shiftg upd-Gal4; magu[e] /magu[f]; MKRS  1 (5)  1 - 2 0 - 2  
upd-Gal4; magu[e] /magu[f]; UAS-V5-magu 3.5 (10) 3 - 6 2 - 6 <0.01 
upd-Gal4; magu[e] or [f]/CyO; MKRS 4 (9) 3 - 4 2 - 5  
upd-Gal4; magu[e] or [f] /CyO; UAS-V5-magu 5 (9) 5 - 6 2 - 8 <0.05 
a Alleles used: [e]=[e00439]; [f]=[f02256]. 
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th percentile, Q[1] = the 25th percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e Calculated for early and late shift rescue samples.  
f
 Number of testes scored in parentheses 
g 1st and 2nd instar larvae (early shift) or 3rd instar larvae and early pupae (late shift) raised at 25oC were moved to 29°C until 
eclosion. Adult flies (0-3 days of age) continued grown at 29oC for 3 days. 
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Figure 5. CySCs and hub cells are maintained in magu mutants. The genotype for 
magu/+ is mague00439 or maguf02256/CyOkr-Gal4UAS-GFP, and for mutant is 
mague00439/maguf02256. Hub (FascIII, white); CySCs (Zfh1, red); cycling cells (Edu in B 
and F, green); DNA (Hoechest, blue). (A and B) The number of CySCs in magu/+ (A) 
and mutant (B) testes was similar. (C and D) magu mutant CySCs (D, arrowhead) divided 
normally as magu/+ (C, arrowhead). (E and F) Visualized by FascIII and DNA stainings, 
the number of hub cells appeared similar in magu/+  (E) and mutant (F) testes. (G and H) 
Using another marker (upd>GFP, green), the hub cell number in magu/+ (G) and mutant 
(H) was also similar. 
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Table 4. magu does not affect CySCs or hub cells   
 Genotype a P value            
(Student’s T-Test) 
 magu[e]/magu[f] Sibling Control 
Average CySC number b  21.7 ± 1.0 (16) c 21.9 ± 1.0 (14) >0.5 
S-phase index for CySCs d  0.2 ± 0.03 (10) 0.2 ± 0.01 (10) >0.5 
Average hub cell number e   9.6 ± 0.4 (20) 9.9 ± 0.5 (17) >0.5 
Average hub cell number f   7.8 ± 0.5 (19) 8.0 ± 0.5 (20) >0.5 
a Alleles used: [e]=[e00439]; [f]=[f02256]; Sibling control=magu[e] or [f] /CyOkr-
Gal4UAS-GFP 
b CySC number was scored in 0-4 day adults at 25oC.  
c Number of testes scored in parentheses 
d The fraction of EdU+ Zfh1+ cells to total Zfh1+ cells, in 1-4 day adults at 25 degree. 
e Hub cell number was scored using FascIII and DNA staining, in 0-3 day adults at 
25oC.  
f Hub cell number was scored using Upd-Gal4 UAS-GFP and DNA staining, in 0-3 day 
adults grown  at 25oC and aged at 29oC for 3 days.  
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Figure 6. The CySCs in magu mutants are not differentiated. The genotype for magu/+ is 
magudeletionI/CyOKrGFP, and for mutant is magudeletionI/magudeletionI. Hub (FascIII, white); 
somatic cells (Traffic jam, green); and differentiated cyst cells (Eya, green). (A-B’) 
Similar to magu/+ (A’ arrowheads), the differentiated cyst cells in mutant testes 
presented far away from the hub (B’, arrowhead). The somatic cells close to the hub, 
including CySCs, were not differentiated (A and B, green). Notice the differentiated cells 
had a larger size than undifferentiated somatic cells. (C and C’) The larger-sized 
differentiated cells occasionally appreared next to hub cells in magu mutants (C’, 
arrowhead) 
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Figure 7. BMP signaling is impaired 
in magu mutants. The genotype for 
magu/+ is magudeletionI/ CyOKrGFP 
in A and E, mague00439 or 
maguf02256/CyOKrGFP in C, and 
mague00439bam-GFP/CyOKrGFP in 
G. Correspondingly, the genotype for 
mutant is magudeletionI/magudeletionI in 
B and F, mague00439/maguf02256 in D, 
and mague00439bam-GFP/maguf02256 
in H. Hub (FascIII or E-Cadherin, 
white); germ cells (Vasa, green). (A 
and B) The activation of JAK-STAT 
signaling (Stat, red) remained 
unchanged in mutant testes (B) 
compared to magu/+ (A). (C-F) The 
activation of BMP pathway (pMad, 
red) was reduced in magu mutant 
GSCs (D and F) as compared to 
magu/+ (C and E). C and D were 
adult testes, and E and F were 
gonads from 3rd instar larvae. Notice 
the BMP signal was not restricted to 
GSCs, but also appeared in 
gonialblasts (C and E, arrowheads). 
(G and H) The tip of a magu/+ testis 
exhibited high bam expression in 
spermatogonia away from the hub 
(G), whereas a magu mutant testis tip 
showed bam expression in the germ 
cell adjacent to the hub (H, 
arrowhead). (I and J) GSCs were 
restored in magu mutants when BMP 
signaling was overactivated in the 
germline (J).  
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Figure 8. magu affects L5 specification. (A) Positions of primordial longitudinal veins 
(L2-L5) in late 3rd instar wing disc. The boundary between anterior (A) and posterior (P) 
compartments and that between dorsal (D) and ventral (V) compartments are shown as a 
blue and a dotted red line, respectively (copied from Fig.1A in ref (76)). In following 
panels, anterior is up, dorsal is left. (B) In situ hybridization in wildtype 3rd instar wing 
disc revealing magu RNA mainly in periphery cells on wing blade (arrow). The 
expression of magu also appeared in the notum region of wing disc (arrowhead). (C) 
magu/+. Anti-Delta revealed L3-L5 (arrows) on the wing blade. The staining for L4 was 
often much weaker than L3 and L5. (D) mague00439/magudeletionI. In mutants, only L3 was 
visible by anti-Delta (arrow). The fact that L4 was not detectable on this particular wing 
disc was likely due to the variability of anti-Delta to mark L4. (E-H) Only the posterior 
compartment is shown. (E) magu/+. Anti-DSRF marked intervein cells. L4 and L5 were 
revealed as gaps between interveins (arrows). (F) mague00439/magudeletionI. The region of 
interveins appeared narrower and disorganized in mutants. L4 could be determined based 
on anti-DSRF staining, but the periphery position of L5 made it harder to be identified 
unambiguously (arrows). (G) magu/+. Antibody against Abrupt, a L5 organizer 
downstream of BMP activation, revealed L5 on the sibling control wing discs. (H) 
mague00439/magudeletionI. Anti-Abrupt staining was present in the presumptive L5 region, 
but the signal appeared weak, and the pattern was not as discrete compared to magu 
heterozygotes.  
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Table 5.  The genetic interaction between magu mutant alleles and gbb1 
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - 
Max c 
P value d 
 
0-3 days, 
25oC 
magu[e] /SM6a or gbb1/CyO 7 (10) e 6 - 7 5 - 9  
magu[e] / gbb1 6 (10) 5 - 6 5 - 7 >0.05 
magu[f] /SM6a or gbb1/CyO 7 (10) 6 - 7.8 5 - 8  
magu[f] / gbb1 5.5 (8) 4 - 6 3 - 6 <0.01 
13-16 days, 
25oC f 
magu[e] /SM6a or gbb1/CyO 8 (15)  5 - 9 3 -10  
magu[e] / gbb1 4 (16) 3 - 5 2 - 9 <0.01 
magu[f] /SM6a or gbb1/CyO 4 (18) 4 - 6 4 - 10  
magu[f] / gbb1 4 (19) 3.5 - 5 2 - 7 >0.05 
a Alleles used: [e]=[e00439]; [f]=[f02256]. 
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th 
percentile, Q[1] = the 25th percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e
 Number of testes scored in parentheses 
f
 Animals (0-3 days of age) raised at 25oC were aged at 25oC for 13 days. 
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Figure 9. Dlp is expressed ubiquitously in testis. (A and B) Using two different wildtype 
fly lines (w1118, A; Oregon R, B), the expression of Dlp (red) appeared among many 
cells at the testis tip, and was never restricted to the hub (A', B', white). (E) In contrast, 
Dlp (green) was reported previously to specifically accumulate at hub cells in the Oregon 
R background (E', red; copied from Fig.4E in ref (75)). 
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    Table 6.  The genetic interaction between magu mutant allele and HSPG 
 
 
 
 
 
 
 
 
 
 
 
 
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - 
Max c 
P value d 
 
0-3 days, 
25oC 
magu[delI]; TM6b, Hu, Tb 8 (5) e 7 - 9 6 – 9  
magu[delI]; dally[80]dlp[A187] 9 (5) 9 - 10 9 - 11 >0.05 
12-15 days, 
25oC f 
magu[delI]; TM6b, Hu, Tb 5 (5)  3 - 6 3 - 6  
magu[delI]; dally[80]dlp[A187] 5 (5)  5 - 5 4 - 9 >0.05 
magu[delI]; TM6b, Hu, Tb 5.5 (14)  4.3 - 6.8 3 - 9  
magu[delI]; dlp[A187] 7 (18)  5 - 8 4 - 11 >0.05 
magu[delI]; TM6b, Hu, Tb 5 (9)  4 - 5 4 - 8  
magu[delI]; sfl[9B4] 7 (9)  6 - 7 4 - 9 0.042 
magu[delI]/CyO 7 (9)  6 - 8 3 - 11  
magu[delI]/ttv[63] 6 (10) 5.3 - 7 4 - 8 >0.05 
a Allele used: [del I]=[deletionI]. 
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th 
percentile, Q[1] = the 25th percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e
 Number of testes scored in parentheses 
f
 Animals (0-3 days of age) raised at 25oC were aged at 25oC for 12 days. 
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Table 7. Ectopic expression of Dlp can rescue magu mutant.  
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - 
Max c 
P value d 
 
% of 
Testes 
w/GSCs 
P value e  
 
0-3 days, 
25oC  
UAS-dlp-GFP or fM7; magu[e] /magu[f]; MKRS 0 (19)  0 - 0 0 - 6  21  
UAS-dlp-GFP; magu[e] /magu[f]; nanos-Gal4 2 (21) 0 - 4 0 - 9 0.06 57 <0.01 
12-15 days, 
25oCg 
UAS-dlp-GFP or fM7; magu[e] /magu[f]; MKRS 0 (15)  0 - 0.5 0 - 5  27  
UAS-dlp-GFP; magu[e] /magu[f]; nanos-Gal4 2 (17) 0 - 3 0 - 4 0.15 59 <0.01 
a Alleles used: [e]=[e00439]; [f]=[f02256].  
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th percentile, Q[1] = the 25th percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e Calculated by Chi-square test. 
f
 Number of testes scored in parentheses 
g
 Animals (0-3 days of age) raised at 25oC were aged at 25oC for 12 days. 
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Figure 10. Magu controls the localization of ectopic Dlp expressed in germ cells. UAS-
dlp-GFP was driven selectively in germ cells by nanos-Gal4. (A) magu/+; nanos>dlp-
GFP. In sibling control testes, anti-GFP (green) revealed ectopic Dlp proteins 
accumulated along the interface between hub cells (FascIII, white) and GSCs (Vasa, red)  
(A', arrow). (B) mague00439/magudeletionI; nanos>dlp-GFP. In magu mutants, Dlp (green) 
was not restricted to the hub-GSC interface; rather, it exhibited a punctate staining in and 
surrounding GSCs (B', arrow). 
 
 
 
 
  
Figure 11. Ectopic Dlp expressed from hub cells (
localization in magu mutant. The extracellular Dlp was visualized by staining non
permeablized testes. (A) 
enriched on the outer layer of th
hub cells and GSCs (A', arrow). (B) 
testes, extracellular Dlp exhibited a punctate staining along the hub
accumulation of Dlp was also observed inside the hub (B', arrow). (C) 
mague00439/magudeletionI; hh>dlp
region appeared polygonal, rather than rounded like the hub. The membrane
extended beyond hub cells expressing E
next to the hub (arrow). 
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Figure 12. Magu may not interact with several ECM-associated proteins. (A) WT. Anti-
Perlecan (red) revealed basal lamina under the sheath of testis. A hazy staining was also 
observed near the hub (FascIII, white), suggesting an ECM enrichment in that region 
(arrow). (B) magudeletionI/ magudeletionI. Perlecan appeared normal in most mutant testes 
(data not shown). But in some mutants, the Perlecan staining exhibited multiple layers 
along the testis sheath. Occasionally, basal lamina revealed by anti-Perlecan arced further 
into the testis (arrow). We did not think this was a primary defect in mutants (see text for 
details). (C) TypeIV Collagen-GFP trap line. Similar to Perlecan staining, anti-GFP 
(green) revealed basal lamina under the testis sheath. Two layers of Collagen near the 
hub (arrow) also suggested an accumulation of basal lamina. (D) TypeIV Collagen-GFP 
trap line. Location of extracellular Magu (red) did not overlap with Collagen (GFP) in 
wildtype condition. (E) magu/+. Integrin (red) was expressed ubiquitously in testis tip, in 
somatic cells (Vasa negative) and along the testis sheath.  
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Discussion 
      Here, by following up on a previous microarray approach that identified transcripts 
enriched at the testis tip, we show that magu plays an important role in GSC maintenance. 
We also provide strong evidence that it does so by modulating BMP activation in germ 
cells. magu encodes a secreted protein of the SPARC/BM-40/osteonectin family, shown 
to ensure the proper activity gradient for the BMP morphogen, Dpp, across the 
developing wing epithelium (66). More recently, two groups further showed that Magu 
functions as an important mediator of scaling Dpp signaling activity with wing disc size 
(77, 78). The role we have characterized for Magu in the testis niche exhibits some 
similarities as well as differences to that proposed for the wing.  
 
Magu serves as a BMP modulator to maintain GSCs in adult testes  
      It has been shown that the BMP pathway is activated and required in GSCs, whereas 
the JAK-STAT pathway is activated and required in both GSCs and CySCs (40, 42, 44, 
45, 47, 50-52). Our data shows that magu is required for maintenance of GSCs, but not 
CySCs, and that BMP activation was impaired in germ cells adjacent to the hub in magu 
mutants. We also found that forcing activation of the BMP pathway in germ cells 
substantively rescued the magu phenotype. Thus, we conclude that the primary role of 
magu in the testis niche is to modulate BMP signaling and thereby maintain GSCs.   
      Superficially, our results suggest that Magu works in a manner similar to that 
described in the wing epithelium, where Magu facilitates the transport of BMP ligands to 
establish the proper signaling gradient. However, in our view, the role of Magu in BMP 
signaling is tissue-dependent: it serves as a facilitator for ligand distribution in the wing, 
but a signaling co-receptor in the testis. Our evidence is elaborated upon next.  
       The most obvious difference between testis and wing is that to control wing 
patterning, BMP signaling is graded and must be effective over a long range. Thus, Dpp 
is expressed from a stripe of cells in the center of the wing disc, while the region where 
BMP activation is modulated by Magu is located far laterally, many tens of cells away 
from the ligand source (66). In striking contrast to this situation, BMP ligands are 
produced in hub cells and CySCs of testes, which are directly adjacent to GSCs, where 
pathway activation is required (50, 52). In the testis, there is no documented graded 
requirement, and, if anything, it is likely that pathway activation must be restricted to 
cells near the niche to ensure that few cells take on stem cell character. Therefore, while 
Magu is thought to assist the movement of Dpp over a long range in the wing (66), there 
is no need for long-range transport for GSC maintenance in the testis. This distinction 
between the two systems suggests that key mechanistic differences remain to be 
uncovered for how Magu affects BMP signaling. 
      One way that Magu supports robust signaling far from the BMP ligand source in the 
wing is that magu gene expression is engaged by a feedback circuit in order to be used as 
a positive modulator of signaling. Thus, magu expression is repressed in areas of 
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relatively high signaling, and that repression is relieved in regions of low signaling. Its 
action in the low signaling region is to promote signaling even though these areas are far 
from the ligand source (66). In fact, expressing magu ectopically in the area of high 
signaling serves to dampen signaling there, while it enhances signal at a distance, 
presumably by promoting movement or stabilization of the ligand. In the testis niche, we 
do have some evidence for feedback regulation. We found that a reporter construct of 
Magu, containing pMad/Medea/Schnurri complex binding sites (66) is expressed in hub 
cells, as one would expect. However, when these binding sites are mutated, the reporter is 
expressed more robustly, and in more hub cells. This suggests that feedback exists in the 
testis system also. However, in contrast to the wing, we have no evidence that this 
negative feedback regulation is necessary in the testis niche, as overexpression of magu 
did not result in fewer GSCs (data not shown).  
      One other potential difference between the wing and testis niche is that the BMP 
ligands acted on by Magu might differ in the two systems. Vuilleumier et al. have 
addressed the function of Magu with respect to Dpp, the principal BMP ligand used 
globally for wing patterning. However, the major BMP ligand for male GSC maintenance 
appears to be the related molecule, Gbb (50, 52). This difference could have 
consequences for the mechanism by which Magu influences BMP signaling comparing 
the two systems. For example, although Dpp does not interact directly with Magu (66), 
the potential remains that Magu might bind to Gbb for GSC maintenance. In this regard, 
it is worth noting that gbb is expressed throughout the wing (69), and that compromising 
gbb function does generate a wing vein phenotype similar to magu mutants (70, 71). Thus, 
in the wing, even though the focus has been on Dpp, perhaps there is an effect also on 
Gbb signaling that has yet to be characterized. Thus, further investigation of the 
modulation of BMP signaling by Magu in both the wing and testis niche should be 
revealing.   
 
How might Magu modulate BMP signaling in the testis niche? 
      The fact that overexpressing a constitutively active form of BMP type I receptor in 
the germline can rescue the GSC phenotype suggests that Magu acts upstream of receptor 
binding. This is in agreement with its proposed role in the wing and also preliminary 
analysis in zebrafish (66). There are a number of membrane-associated and secreted 
factors that Magu might influence to modulate BMP signaling.  
      In the wing, Magu interacts directly with Dally, a HSPG (heparan sulfate 
proteoglycan) (66). Interestingly, Dally and its homologue Dally-like (Dlp) are also 
important for male GSC maintenance (74, 75). While we have not observed genetic 
interactions between magu and dally, dlp or other genes needed for HSPG biosynthesis, 
some preliminary data indicate that overexpressing dlp in the germ cells can increase the 
fraction of testes retaining GSCs among magu mutants. Preliminary data also showed that 
ectopically expressing dlp from germ cells led to an enrichment of Dlp along the hub-
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GSC interface, and that this enrichment was Magu-dependent. This suggests a 
hypothesized model of how Magu regulates BMP activation. Studies from other tissues 
have demonstrated that Dlp acts as a BMP co-receptor to recruite ligands and facilitate 
ligand-receptor binding (79). Thus, Magu may concentrate Dlp to the hub-GSC interface, 
and thereby activate the BMP signaling robustly in the specific region (Fig.13A). Without 
the presence of Magu, Dlp proteins are not enriched along the hub-GSC interface. 
Consequently, fewer BMP ligands can be recruited, and BMP activation is diminished 
(Fig.13B). Although this simple model is consistent with our data, it is worth noticing 
that Dlp is expressed ubiquitously in testes, therefore, further experiments are needed to 
examine the role of endogenous Dlp with respect to Magu. In addition, the location of 
another HSPG, Dally, is also reported to be hub specific, thus we can verify the specific 
expression pattern of Dally, and further test its interaction with Magu in GSC 
maintenance (74, 75)  
      Given that Magu is secreted from hub cells, its localization could have suggested a 
more specific hypothesis for its action in the testis niche. However, magu protein 
localization among cells of the niche appears complex. An antibody we raised against an 
N-terminal portion of Magu exhibits punctate signal restricted among hub cells, and at 
the hub-GSC interface, but this serum was effective only sporadically. A second serum 
directed against a C-terminal peptide (66) robustly exhibits the same punctate pattern 
among hub cells, but also reveals a slightly extended distribution among stem cells and 
their daughter cells near the hub. Additionally, this serum revealed strong punctate signal 
likely among the extracellular matrix (ECM) near the hub. It is not possible at this time to 
distinguish whether the pool of Magu associated with ECM or the more generally 
distributed pool is active for GSC maintenance.  
      However, considering the close proximity of hub cells to GSCs, it is simplest to 
envision that Magu acts along the hub cell-germline stem cell interface. In fact, the BMP 
signals from the hub are received at the hub-GSC interface, as visualized by a fluorescent 
reporter of BMP type I receptor Thickvein (63). It is possible that Magu facilitates 
interactions between BMPs and their receptors via formation of ternary 
ligand/Magu/receptor complex. Such a ternary complex has been shown for 
Crossveinless 2 (Cv2), an extracellular BMP modulator engaged for crossvein patterning 
in the wing (80). Although Cv2 and Magu do not encode similar proteins, perhaps some 
lessons can be learned from the role of Cv2. This protein can also bind to Dally, and the 
Cv2-HSPG interaction is important for normal BMP signaling in crossvein patterning 
(80). Magu and its vertebrate orthologues SMOC1/2 have two Thyroglobulin type-1 
repeats. It has been shown that proteins with such repeats can inhibit extracellular 
proteases (81). Thus, although Cv2 appears to have no effect on the function of Tolkin, 
the protease promoting BMP signaling in crossvein patterning (80), it is reasonable to 
speculate that Magu may function as a protease inhibitor to protect BMP ligands from 
being degraded by other extracellular proteases. 
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      Alternatively, the enrichment we observed among the ECM is interesting. Thus, we 
explored possible roles and interactions extracellular matrix components may have with 
Magu. First, among the family of proteins to which Magu belongs, SPARC interacts with 
type IV Collagen, a component of basement membrane (82), and SMOC1/2 are 
associated with basement membrane (83, 84). Interestingly, Viking (Vkg), the type IV 
collagen in Drosophila, is involved in female GSC maintenance.  However, its role is to 
restrict BMP signaling in the germarium (85), and this would be opposite to the 
phenotype expected for a Magu interactor in the testis niche.  In addition, we did not 
observe a defect of type IV collagen in magu mutants, or co-localization of type IV 
collagen and extracellular Magu in wildtype testes. Second, we tested another ECM 
component, Perlecan, but this also appeared to accumulate normally in magu mutant 
testes. Finally, since SMOC2 depends on intergrins to modulate the attachment of 
epidermal cells and for angiogenesis (86, 87), we also investigated the possible 
interaction of Magu and integrins in testes. But we did not observe a defect of βPS-
Integrin in magu mutants.  
 
Speculation about other roles Magu may play in adult testes  
      The extended staining pattern at the testis tip as visualized by antibodies against C-
terminal Magu is interesting. BMP ligands are expressed by hub cells and CySCs, and 
pMAD accumulation can often be detected in the second tier germ cells, even though 
these cells are not GSCs. Perhaps Magu is assisting in BMP signaling at these extended 
distances, playing a role more similar to that in wing as a ligand transporter. While we 
have no direct data that Magu plays such a role in the testis, a mild extension of BMP 
activation could act in dedifferentiation.  For example, it may confer a stronger tendency 
for dedifferentiation on daughter germ cells near the hub. In fact, it has been shown that 
early rather than late stage spermatogonia are more likely to restore the GSC population 
(49).  
      Finally, punctate Magu staining can be observed in regions of testes far away from 
the hub, as shown by both antibodies against Magu. We do not know whether these 
signals are real, but it is worth noting that BMP signaling plays a role in later stage cyst 
cells where this pathway must be activated (62). It is possible that Magu may facilitate 
the distribution of BMP ligands from the hub region down to the area where 
spermatogoina are located. To demonstrate this hypothesis, live imaging of ligand 
transportation using epitope tagged Dpp/Gbb and Magu are needed.  
 
Does Magu play a role in GSCs in larval gonads? 
      It has been shown that JAK-STAT pathway is required for both GSC and CySC 
establishment during Drosophila embryogenesis (68, 88). Male GSCs are established 
during the embryo-larval transition (68). Although no experiments have been reported to 
directly test the requirement of  BMP in GSC establishment, a consistent pMad staining 
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in early germ cells is not detectable until 4hrs after larva hatching (89). We have found 
that GSC number is normal in 1st instar larva gonads mutant for magu. Thus we conclude 
Magu does not affect GSC establishment. Therefore, it is likely that BMP pathway is not 
involved in GSC establishment.  
      Nevertheless, once GSCs are established, Magu starts to act in their maintenance. 
This conclusion is based on the observation that 3rd instar larva gonads mutant for magu 
have a significantly lower number of GSCs compared to sibling controls. We have 
noticed that there is normally an increase in GSC number from 1st to 3rd instar. This 
observation is supported when comparing data reported by two other groups (68, 89). 
However, Magu mutants do not show such an increase, thus BMP signaling must be 
necessary for this increase.   
 
Evidence for dynamic BMP signaling in Drosophila male GSCs during development  
      The requirement of BMP signaling for GSC maintenance has been well established. 
In adult testes, GSC clones mutant for components in BMP signal transduction are not 
maintained, but instead differentiate (50-52). This suggests strongly that the BMP 
pathway is active in adult GSCs.  However, in contrast to earlier reports (50), we have 
difficulty detecting BMP activation in wildtype testes using either pMAD or reporter 
gene assays. While this might imply that the level of BMP pathway activity is below the 
threshold of our detection, positive pMAD staining can be always nicely observed in 3rd 
instar larva gonads. Furthermore, a recent paper from the Fuller lab fully supports our 
observation (89). Chang et al. go on to show that the response to BMP signaling in GSCs 
is downregulated during development as demonstrated by pMAD and dad-LacZ stainings. 
This downregulation is mediated by Smurf, an ubiquitin protein ligase for MAD 
degradation. In smurf mutant adult testes, high levels of pMAD and dad-LacZ expression 
are observed in GSCs and early germ cells. Smurf also controls GSC numbers. In 
wildtype situation, the average GSC number in testes is significantly lower in adult 
compared to pupa. However, this difference is abolished in smurf mutants. These data are 
consistent with the observation in our cohort experiment that GSC number in 3rd instar 
larva gonads is slightly higher than that in adult testes (Table 2). Taken together, the data 
suggest strongly that there is indeed a temporal regulation of BMP signaling in GSCs 
during testis development.   
 
Is BMP signaling activated in hub cells of adult testes? 
      It has not been reported before that BMP activation occurs in hub cells. However, 
Magu is a target gene of BMP pathway (66), and is expressed in hub cells. In addition, 
antibody staining against Medea and expression of dad-LacZ also suggest BMP 
activation in hub cells. Therefore, we think BMP signaling is activated in hub cells. 
Considering the heterogeneous pattern of magu and dad reporter lines (Fig.1B; 
Addendum Fig.1B, B’), we also conclude that the activation of BMP pathway in hub 
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cells is spatially regulated. We do not know the importance of BMP activation at the hub, 
besides stimulating magu expression. It is intriguing to think that the non-uniform 
activation may indicate functional heterogeneity among hub cells. Further evidence 
would be needed to test this speculation. But, this idea may be supported by the fact that 
hub cells derive from two groups of somatic gonad precursors during embryonic 
development: one from parasegment 10, and the other from parasegment 11.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 13. A hypothesized model of how Magu regulates BMP activation
wildtype testis, Magu concentrates Dlp to the hub
proteins recruit BMP ligands to the surface of BMP receptors, thereby facilitate the 
activation of BMP signaling
the GSC membrane surface, thus BMP ligands are not concentrated along the hub
interface, and BMP activation is diminished. 
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Material and methods 
Fly strains  
      Fly lines used were: magufrgII-LacZ, magufrgII∆S-LacZ, and UAS-V5-magu 
(George Pyrowolakis, University of Freiburg, Germany), nanos-Gal4:VP16 (Erica Selva, 
University of Delaware, USA), upd-Gal4 (Erika Matunis, John Hopkins University, 
USA), upd-Gal4 UAS-GFP (Erika Bach, New York University, USA), bam-GFP (Dennis 
McKearin, UT Southwestern, USA), UAS-tkvA (Kristi Wharton, Brown University, 
USA). All stocks related to HSPG came from Xinhua Lin, Cincinnati Children's Hospital 
Medical Center. The following transposable insertion lines were from the Exelixis 
Collection at Harvard Medical School: magud00269 (FBti0053977), mague00439 
(FBti0046433), and maguf02256 (FBti0050490). All other stocks including maguKG02847b 
(FBti0023111) were provided by the Bloomington Stock Center or generated in this study. 
Flies were grown at 25ºC unless noted.  
 
Generation of magu mutants 
      A precise excision of mague00439 was isolated as described to generate a revertant, 
while deletion I was made using FRT/FLP-mediated hybrid element insertion starting 
with the PiggyBac insertions magud00269 and maguf02256 (90). The resulting lines were 
verified by PCR. Some of the same mutant alleles were independently made and reported 
previously (66). To obtain mutants with potentially larger deletions, the P-element 
transposon KG02847b was remobilized, and new lines exhibiting a wing vein phenotype 
over the mague00439 allele were selected out. Inverse PCR was used to identify the 
endpoints of the resulting deletions. The deletions begin in the KG element, and extend to 
genomic coordinate 5966K for line 76 (reported in Table 1), 5987K for line 123, 6325K 
for line 166, 5988K for line 862 (Flybase, release before Feb. 2010).  
 
Generation of an anti-Magu antibody 
      A 6xHis epitope tag (Qiagen pQE vector) was fused N-terminally to residues 36-213 
of Magu. The resulting protein was purified from soluble whole bacterial extracts, using 
Ni-NTA beads (Qiagen), and injected into rabbits. The crude sera were preabsorbed 
1:5000 against fixed w1118 testes at 4ºC for 24 hrs. Titration of this antibody revealed 
that the preabsorbed 1:5000 dilution gave the best signal-to-noise ratio.   
 
Plasmids 
      magu sequence was amplified via PCR from BDGP cDNA LD30894, and cloned 
using Gateway recombination methods (Invitrogen) into either a pUAST-Myc or 
pUAST-GFP destination vector (developed by Terence Murphy, DGRC). Transgenic 
flies were produced using standard germline transformation techniques.  
 
In situ hybridization  
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      In situ hybridization on testes and wing imaginal discs using digoxigenin-labeled 
antisense RNA probes was performed as previously described (64).  
 
Immunostaining  
      Immunostaining for gonads, adult testes, and wing imaginal discs was performed as 
previously described except 1×PBS was substituted for Buffer B (40). The following 
antibodies were used: mouse anti-lacZ (1:10,000, Promega), rat anti-E-Cadherin (1:20, 
DSHB), rabbit anti-Magu (1:5000), rabbit anti-Magu (1:15,000, George Pyrowolakis, 
University of Freiburg, Germany), goat anti-Vasa (1:400, Santa Cruz), mouse anti-FascIII 
(1:50, DSHB), rabbit anti-α-Spectrin (1:200, DSHB), rabbit anti-Zfh1 (1:5,000, Ruth 
Lehmann, New York University, USA), chick anti-GFP (1:1000, Molecular Probes), 
rabbit anti-Stat (1:5000, Erika Bach, New York University, USA), mouse anti-pMad 
(1:1000, Carl-Henrik Heldin, Ludwig Institute for Cancer Research, Sweden), mouse 
anti-Eya (1:20, DSHB), guinea pig anti-Traffic jam (1:10,000, Dorothea Godt, University 
of Toronto, Canada), mouse anti-Dlp (1:50, DSHB), mouse anti-Delta (1:3000), mouse 
anti-DSRF (1:200), and rabbit anti-Abrupt (1:1000). Attempts to visualize pMad in adult 
testes using anti-pMad generally failed. In one experiment, several testes exhibited 
clearly positive signals. The example in Fig 5C is from this experiment. 
      For extracellular staining, testes were dissected in cold Ringer’s solution, and 
incubated for 2 to 3 hrs in cold Ringer’s solution containing 2% normal donkey serum 
and 1:15,000 rabbit anti-Magu (developed by George Pyrowolakis), and washed for 3×20 
min in cold Ringer’s solution, followed by the standard fixation and immunostaining 
protocol.  
 
Imaging and imaging analysis 
      Images were captured with a Zeiss Axioplan 2 equipped with an apotome. Z-series 
were analyzed by the AxioVision 4.6 software, except that projection images for Magu 
(standard staining), α-Spectrin, and pMad (for testes) were created by ImageJ (NIH) 
software. Various cell types were counted by stepping through optical sections. Excel 
(Microsoft) was used for statistical analysis. GSC number in magu mutants did not fall 
into a normal distribution, thus the Mann-Whitney test was used to calculate P-value on 
the VassarStats web site (http://faculty.vassar.edu/lowry/VassarStats.html).    
 
Mounting fly wings 
      Wings from adult flies were dissected in methylsalicilate (Sigma, C1705) and 
mounted in 2:1 Canada Balsam (Sigma, M-6752): methylsalicilate.  
 
S phase labeling  
      S phase labeling of testes was performed as previously described (40).  
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Summary 
      Stem cells are often situated in a special microenvironment called niche. Niche cells 
regulate stem cell behavior through local signals. In Drosophila testes, two stem cell 
populations, GSCs and CySCs share a common niche called the hub. Recent work from 
our lab has demonstrated that CySCs also function as a niche for GSCs (40). We further 
showed that the transcription repressor Zfh1 governs the double role of CySCs (42). Zfh1 
is required for CySCs self-renewal, and also sufficient to induce excess CySCs and GSCs 
(42). How Zfh1 plays its role is ill-defined. Thus here we attempt to identify target genes 
of Zfh1 using complementary approaches. ChIP-qPCR results show that Zfh1 is enriched 
near the cyst cell differentiation gene encoded by eya and the epithelial component E-
Cadherin encoded by shg. The complementary genetic approach suggests that Zfh1 
requires co-repressor CtBP to generate ectopic stem cells.   
 
Introduction 
      Niches regulate the behavior of many tissue-specific stem cells (1). The 
microenvironment formed by niche cells provides important extrinsic cues to guide the 
self-renewal of stem cells. Studies of Drosophila male germline stem cells have served as 
a paradigm in niche-stem cell biology. In the fruit fly testes, a group of tightly packed 
somatic cells, called hub cells, are located at the apical tip. Two intermingled stem cell 
populations, germline stem cells (GSCs) and cyst stem cells (CySCs), are organized 
around the hub. It has been known for more than ten years that JAK-STAT signals 
emanating from the hub are necessary and sufficient for the self-renewal of both GSCs 
and CySCs (44, 45). Stem cells mutant for a JAK-STAT signal transducer will lose their 
stemness and differentiate, leaving the hub (44, 45). When the ligand of JAK-STAT 
pathway is overexpressed in testes, excess GSCs and CySCs are induced, resulting in a 
stem cell tumor phenotype (Fig.1B) (40, 44, 45). Therefore, the hub functions as a well-
established niche to control stem cell behavior through JAK-STAT signaling.  
      This somewhat simple model, where one niche signal is key, has modified 
extensively by recent work from our lab (40). We found that CySCs are also part of the 
niche: they act together with hub cells to renew GSCs. Furthermore, we also significantly 
clarified the role of JAK-STAT pathway in the function of this niche. Surprisingly, when 
JAK-STAT signaling is only activated in the CySCs, GSCs are still maintained even 
though they are not transducing a STAT signal (40). Therefore, STAT cannot be 
necessary for GSC renewal. Interestingly, the stat-depleted GSCs are no longer adherent 
to the hub (40). Thus, JAK-STAT signaling is not required for GSC self-renewal, but 
rather regulates GSC adhesion to hub cells (Fig.1A, copied from Fig.4E in ref (40)). 
Under these conditions the CySCs govern the renewal of GSCs, and thus, CySCs 
constitute part of the germline niche. The novel notion that hub cell and CySC function 
cooperatively to serve as a GSC niche may not be surprising, as hub cells and CySCs are 
derived from a common pool of somatic gonadal precursors (SGPs) during 
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gonadogenesis. Interestingly, the niche architecture and signaling in male gonads has 
been shown to be similar to our observation in adult testes (88). Further evidence 
supporting CySC’s role as part of the niche comes from dedifferentiation studies on 
spermatogonia, daughter cells of GSCs that have already taken on the fate of 
differentiation. Brawley and Matunis have shown that GSCs can be regenerated by 
coaxing spermatogonia to convert back into GSCs (49). They find that the regenerated 
GSCs are often accompanied by CySCs. Their data also indicate that when CySCs or cyst 
cells are not present, spermatogoina are not able to undergo dedifferentiation. Thus, 
CySCs may be required to guide the dedifferentiation of gonial cells into GSCs.  
      The fact that CySCs were not only a stem cell population, but also comprised part of 
the niche has led me to focus on these special cells. From a prior microarray study in the 
lab, a number of genes were identified whose expression was enriched in stem or niche 
cells (64). Among these was the zinc finger homeodomain protein Zfh1. We discovered 
that Zfh1 was highly expressed in CySCs, but downregulated in hub cells and also 
downregulated in differentiating cyst cells (42). Furthermore, CySCs mutant for Zfh1 left 
the hub and started to differentiate (42). Therefore, Zfh1 is specifically required for CySC 
maintenance. More interestingly, when Zfh1 is sustained in otherwise differentiating cyst 
cells, we observe a stem cell tumor phenotype similar to ectopic JAK-STAT activation 
(42). Using various stem cell markers, we have demonstrated that the excess somatic 
cells and germ cells induced in Zfh1 overexpression testes are bona fide stem cells (42). 
Thus, Zfh1 is not only intrinsically sufficient for CySC self-renewal, but also regulates 
GSC self-renewal non-autonomously. The impact of Zfh1 on two cell lineages matches 
with our notion that CySCs function as both a stem cell and a niche for GSCs.  
      How does Zfh1 regulate stem cell behavior? We think zfh1 is a presumptive target 
gene of JAK-STAT. We have shown that the function of Zfh1 is downstream of JAK-
STAT activation, as ectopic STAT proteins are not accumulated in Zfh1 overexpression 
testes (42). Another signal that is required for GSC maintenance is BMP. We have found 
that when BMP signals are impaired, the effect of Zfh1 to cause excess GSCs is 
dampened (40). Thus, we previously proposed a model in which activation of JAK-STAT 
in CySCs induces Zfh1, which in turn induces the expression of BMP ligands required 
for GSC self-renewal (Fig.1A). However, if BMP is the key GSC renewal signal 
downstream of Zfh1 activation, then constitutive activation of the BMP pathway in the 
germline would cause excess GSCs. But this reasonable expectation is not observed in 
testes with ectopic BMP activation in the germline (Fig.1C) (50-52). We have also tried 
to co-activate both JAK-STAT and BMP in the germline, but this attempt also fails to 
recruit extra GSCs (Fig.1D). Thus, there must exist an unidentified GSC renewal signal(s) 
that is controlled by target genes of Zfh1 in the CySCs. 
      Zfh1 is a transcription factor with pleiotropic roles during embryogenesis (91-98). 
The protein contains zinc finger clusters at both the N- and C-terminals. It also has a 
polyQ region, a homeodomain, and a CtBP (C-terminal-binding protein) binding motif. 
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Data from in vitro experiments have shown that the zinc fingers of Zfh1 can bind to 
EBox sites in the regulatory region of a gene (91). It has also been shown that Zfh1 
functions as a transcriptional repressor with the recruitment of its co-repressor CtBP (99). 
We have found out that Zfh1 with a mutation in CtBP binding motif fails to generate 
extra stem cells (42). Thus, we think Zfh1 also acts as a transcriptional repressor in the 
testis.  
      Here, to further dissect out how Zfh1 controls stem cell self-renewal, we are trying to 
identify target genes of Zfh1 using two genome-wide approaches: ChIP-Seq and genetic 
modifier screen. ChIP-qPCR results show that eya and shg may be direct targets of Zfh1. 
We also further demonstrate the requirement of CtBP for Zfh1 function, as lowering the 
gene dose of CtBP reduces the stem cell tumor phenotype generated by Zfh1 
overexpression.  
 
Results 
      To identify target genes of Zfh1, we have taken two approaches. One is ChIP-Seq, 
which combines chromatin immunoprecipitation with high throughput DNA sequencing. 
The other is a genetic modifier screen. ChIP-Seq allows us to identify potential direct 
targets of Zfh1. The gene list generated by ChIP-Seq will be long, requiring much effort 
in prioritization to select out a small set of targets for follow-up analysis. Thus, the 
genetic modifier screen serves as a complementary method to narrow down our focus. 
The screen approach identifies genes functioning either in parallel with or downstream of 
Zfh1. It is an unbiased genome-wide method, but depending on the dosage sensitivity of a 
particular gene, it may not fish out all the potential targets of Zfh1. Therefore, we think 
genes identified from both approaches have a higher chance to be a real Zfh1 target. The 
project is currently underway. Below I will elaborate how we have carried out each 
approach, how far along we are, and what will be required to finish each approach.  
 
ChIP-Seq for Zfh1  
      The general procedure of ChIP-Seq is shown in Fig.2. First, cells of interest are 
enriched, and chromatin and protein are cross-linked using formaldehyde. Second, 
chromatin isolated from cell lysates are fragmented by sonication. Third, 
immunoprecipitation (IP) is performed on chromatin fragments using antibody-
conjugated beads. Forth, pulled down chromatin-protein complexes are isolated, and the 
IP’ed chromatin is eluted by reversing the cross-linking. Finally, purified DNA fragments 
are assembled into a library and sequenced.   
      For the ChIP-Seq approach to be successful, we need to have three essential 
components in place.  
1. Can we isolate enough chromatin from testes for ChIP?  
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      There are only 25 zfh1 expressing cells (CySCs) per testis. In order to have sufficient 
numbers of this cell type from which to isolate chromatin, we decided to significantly 
boost the number of cells expressing zfh1 using the Gal4-UAS system.  
2. Do we have a ChIP-grade antibody for Zfh1?  
      There were various antibodies against Zfh1 generated by different labs (96, 98, 100). 
It was unknown whether they were suitable for ChIP. Alternatively, we could use 
commercially available ChIP-grade antibodies against an epitope tag. In this latter case, 
we needed to construct an epitope tagged UAS-Zfh1.  
3. Can we carry out ChIP in our lab?  
      In order to assess the success of ChIP, we decided to perform qPCR experiments on 
ChIP’ed chromatin before sequencing. We also chose to perform ChIP-qPCR on a 
histone mark as a positive control (trimethyl, lysine 27 on Histone H3; H3K27me3). We 
used IgG as a negative control. No known targets existed for Zfh1 in the testis so far, thus 
we selected putative positive control genes based on our genetic data and a gene list 
generated from Zfh1 ChIP on wildtype embryos (see details later).  
      Our tests for these three essential components are obviously interrelated. The 
reliability of satisfying the requirement for one depends on how reliably the other two 
components function. However, for the sake of clarity, I will summarize results for each 
component separately.  
 
Can we isolate enough chromatin from testes for ChIP? 
      There are two ways to significantly increase the number of zfh1 expressing cells in 
the testes. The first relies on the fact that zfh1 expression is regulated by activation of the 
JAK-STAT pathway in CySCs. Thus inducing the JAK-STAT pathway in the cyst 
lineage would then activate the downstream gene zfh1. The second way involves 
overexpressing zfh1 directly using a cyst lineage Gal4 and UAS-Zfh1. No matter which 
method is used, the key will be to obtain robust production of excess zfh1 expressing 
CySCs. This proved trickier than we had hoped.   
      Since the potential exists that directly expressing artificially high levels of Zfh1 might 
lead to some aberrant binding and increase the false-positive rate, we initially tried 
activating the JAK-STAT pathway. To do this, we expressed either the ligand (Upd), or 
an activated form of the kinase, JAKAct. However, we could not generate testes having 
consistent induction of Zfh1, nor having a robust stem cell tumor phenotype (see 
Addendum).  We therefore had to turn to direct overexpression of Zfh1 in the cyst lineage.  
Even though in the past this approach uncovered a number of key principles about Zfh1 
and CySCs (42), the approach was not robust enough for my purpose, as too many testes 
did not exhibit a strong enough phenotype (see Addendum).  
      We did not know exactly why the penetrance of stem cell tumor phenotype using 
UAS-Zfh1 was low. One reason could be that the genomic insertion site for this 
particular transgene site did not allow high enough expression. To obtain flies with a 
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more consistent phenotype, we generated our own UAS-Zfh1 transgenic lines. We also 
chose to epitope tag the protein. This would be beneficial since we could then use 
commercially available ChIP-grade anti-epitope tag antibodies if necessary.  
• Generating epitope-tagged UAS-Zfh1  
      In order to generate epitope-tagged UAS-Zfh1, we first needed to know which Zfh1 
isoforms were normally expressed in testes. When we began with this approach, two 
isoforms of Zfh1 had been reported in Drosophila embryos (Flybase, Fig.3). Zfh1-PB 
was a longer isoform than Zfh1-PA, and contained two additional zinc fingers and a 
polyQ region at the N-terminus (Fig.3). To test for the presence of transcripts encoding 
the two isoforms in testes, we performed 5’ RLM-RACE (RNA Ligase Mediated Rapid 
Ampilification of cDNA Ends) and RT-PCR (Reverse Transcription PCR) experiments 
using isolated RNAs. We found evidence for Zfh1-RB and an alternative form of Zfh1-
RA in wildtype testes (Fig.3). The variant of Zfh1-RA had a different first exon, but the 
same functional domains as Zfh1-PA. Thus, both Zfh1 isoforms were present in testes.  
      As stated above, an advantage of tagged UAS-Zfh1 was to use anti-epitope tag 
antibodies for ChIP. But one caveat here was that the epitope tag may interfere with the 
function of Zfh1 protein. Thus to investigate whether tagging at the N- or C-terminal was 
the best, we made constructs with the tag at either end. We also chose HA and Myc as the 
tags, because ChIP-grade antibodies are available against these two epitopes. Using 
Gateway Cloning, we successfully generated tagged UAS-Zfh1-RB plasmids. For the 
short isoform, we used UAS-Zfh1-RA-1×Flag-1×HA, a construct from BDGP (Berkeley 
Drosophila Genome Project). However, since transgenic flies with Zfh1-RA-1×Flag-
1×HA expression did not cause stem cell tumor phenotype in testes (see Addendum), 
below I will focus on the tagged UAS-Zfh1-RB lines.  
• N-terminally 3×HA-tagged UAS-Zfh1-RB gives rise to stem cell tumor 
phenotype at 100% penetrance and with high expressivity  
      We successfully generated several transgenic lines with epitope-tagged UAS-Zfh1-
RB. To investigate whether the transgene could be expressed well in vivo, we first 
induced the ectopic proteins in epithelial cells of embryos using Patch-Gal4, a driver 
expressed in a pattern of stripes. We observed this ectopic pattern using antibodies 
against either the epitope tag or Zfh1 (Fig.4B, B’, C, C’). We also noticed that embryos 
with tagged Zfh1-RB did not survive to larval stage. These embryos appeared to be 
disorganized (Fig.4A, B, C), and many cells with ectopic Zfh1 expression exhibited 
bright DNA staining, suggesting the death of cells (data not shown). Since the 
mammalian homologue of Zfh1 activates an epithelial to mesenchymal transition, we 
thought ectopic expression of Zfh1 in epithelium cells may change cell fate, thus causing 
the patterning defect.  
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      To test whether the tagged Zfh1 could cause stem cell tumor phenotype in testes, we 
overexpressed the transgene in cyst lineage. The extent of phenotype varied among 
different transgenic lines (see Addendum Fig.3). But one N-terminally 3×HA tagged 
UAS-Zfh1-RB line gave rise to ectopic CySCs and GSCs at 100% penetrance and with 
high expressivity (Fig.5B). Different from sibling controls, these overexpression testes 
appeared to be bigger and fatter under light microscope (data not shown). This may be 
due to a plethora of extra cells filling the overexpression testes. Ectopic zfh1 expression 
cells could be identified throughout the testes using antibodies against either Zfh1 or HA 
(Fig.5B’, D). These extra Zfh1+ cells were functional CySCs, as excess GSCs marked by 
dotted fusomes were also induced in the overexpression testes (Fig.5B”). Thus, we chose 
to use this N-terminally 3×HA tagged UAS-Zfh1-RB line for the ChIP experiment.  
 
Do we have a ChIP-grade antibody for Zfh1?  
      Now we had an N-terminally 3×HA tagged UAS-Zfh1-RB line suitable for ChIP, we 
could apply the commercial ChIP-grade antibody against HA for our experiment. In 
addition, we tested the various antibodies directly against Zfh1. Since anti-HA and anti-
Zfh1 recognized different epitopes, we thought overlapping ChIP results obtained from 
these different antibodies would be more likely to reflect real Zfh1 targets. However, we 
could not get ChIP to work using anti-Zfh1 antibodies (data not shown). Therefore, 
below I will discuss the anti-HA antibody.  
• The commercially available anti-HA antibody can IP tagged Zfh1 protein, but 
we do not know for sure whether it works for ChIP  
      We took a systematic strategy to assess whether the ChIP could be successful using 
anti-HA. We first detected ectopic Zfh1 proteins in whole cell lysates using an antibody 
against HA raised in rat. We observed a dominant band with the size similar to that 
predicted for Zfh1-PB in protein lysates isolated from overexpression testes (Fig.6A, 
arrow). This finding allowed us to track the tagged protein during each step of the ChIP 
protocol. To investigate whether we can IP the tagged Zfh1, we carried out the IP 
experiment by following the ChIP protocol and using a commercial ChIP-grade anti-HA 
antibody developed in rabbit. We analyzed results from each step of the procedure by 
Western Blot. We could detect tagged Zfh1 in the experimental and not control samples 
(Fig.6B, arrow). Most importantly, we reproducibly saw enriched Zfh1 proteins in IP’ed 
sample (Fig.6C). This demonstrated that the rabbit anti-HA can pull down tagged Zfh1.   
      One difference in the IP protocol above, and that which would be used in the true 
ChIP experiment is that testes used above were not treated with formaldehyde to cross-
link chromatin and protein. We did perform a similar experiment using cross-linked 
chromatin. In this case, instead of a sharp band, we observed smears after Western Blot in 
the size range of Zfh1 both before and after IP (data not shown). We believe it is 
reasonable to assume that this is due to the cross-linking. Alternatively, it could reflect 
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some other problems with the procedure, and should be followed up in the future if 
necessary. 
 
Can we carry out ChIP in our lab? 
• Predicting target genes of Zfh1  
      For ChIP-qPCR, we selected three genes as putative targets of Zfh1: eya, mys, and 
shg. The rationale for choosing each gene is stated below.  
      The gene eya is expressed in differentiating cyst cells, but not CySCs. Previous work 
in our lab showed that expression of eya in CySCs is repressed by Zfh1, as CySCs mutant 
for zfh1 started to express eya and differentiated directly rather than remaining as CySCs 
(42). We hypothesized that eya might be directly regulated by Zfh1 through cis-
regulatory regions. To identify potential binding regions of Zfh1, we examined the 
expression pattern of two lacZ reporter lines for eya (Figure 7) (101). The expression of 
C1-LacZ recapitulated the Eya testis pattern, exhibiting expression in later, differentiating 
cyst cells (Fig.7A). In contrast, the A3-LacZ reporter exhibited precocious expression, 
now in CySCs in addition to later differentiating cyst cells (Fig.7B). These two regions 
might contain Zfh1 binding sites. In particular, since Zfh1 was predicted to act as a 
repressor, it might bind better to C1, which recapitulated the endogenous Eya pattern, 
compared to A3, which exhibited precocious expression in CySCs (where Zfh1 was 
expressed).  
      Another putative target that we selected was mys, which encodes βPS-integrin. It has 
been shown that integrin accumulated at the hub-CySC interface, and that integrin was 
necessary for the attachment of CySCs (47). Thus mys needed to be expressed in CySCs, 
however, its expression had to be maintained at a relatively low level at this interface; 
otherwise, CySCs would outcompete GSCs for position in the niche (47).  Low level mys 
expression was achieved by repression due to JAK-STAT signaling in CySCs (47). 
Because Zfh1 was predicted to be a transcriptional repressor downstream of JAK-STAT 
activation, we hypothesized that Zfh1 controlled mys expression, and thus, selected mys 
as a potential positive control in our ChIP. A second reason for the selection of mys was 
that the White lab had generated a gene list from Zfh1 ChIP-chip using chromatin 
prepared from wildtype embryos (100). While the data from that experiment was not 
confirmed yet (see Discussion), mys was present on their list.    
      A third possible target of Zfh1 is shg, the Drosophila homologue of E-Cadherin. We 
chose this gene because ZEB1, the mammalian homologue of Zfh1, represses Cadherin 
directly. This seems also true in fruit fly testis development. During gonadogenesis, Zfh1 
is initially expressed in all somatic gonad precursors (SGPs) (88). A subset of SGPs will 
then lose Zfh1 expression as they adopt hub cell fate, and these cells exhibt increased E-
Cadherin expression (88, 102). Some of the remaining SGPs retain high Zfh1 expression 
and adopt CySC fate, and these cells exhibit relatively low level of E-Cadherin 
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expression (88, 102). This reciprocal expression pattern of Zfh1 and E-Cadherin is also 
observed in adult testes (Fig.7C). To further test the notion that Zfh1 repressed E-
Cadherin, we expressed Zfh1 ectopically in the hub cells of adult testes. This greatly 
diminished the enrichment of E-Cadherin in hub cells (Lindsey Wingert, Fig.7D). Thus 
we concluded that Shg can be (genetically) suppressed by Zfh1. It was worth noting that 
shg also appeared on the embryo list made by the White lab.  
      Once we selected putative target genes, we narrowed down the genomic region for 
which qPCR primers will be designed. For eya, we already knew the sequence of A3 and 
C1, but the length of each fragment was more than 5kb. To further pinpoint the sub-
region, we searched for Ebox sites in the two fragments. It has been shown that the zinc 
fingers of Zfh1 bind to the consensus Ebox sequence, CACCTG in vitro (91). We 
identified multiple Ebox sites in A3 and C1 fragments using the software DNASTAR 
(Fig.8). For mys and shg, we initially scanned the binding region from the embryo ChIP-
chip data, but found no Ebox site in either (denoted as mys-772 and shg-346 in Fig.8). 
Thus we further searched regions downstream, and identified Ebox sites around the start 
codon of each gene (Fig.8). Thus, we designed qPCR primers flanking each EBox site, 
with the size of PCR fragment close to 100bp (Fig.8).  
• ChIP on H3K27me3 can be reproducibly carried out 
      It is widely agreed that transcription factor ChIP is tough to achieve successfully, as 
the abundance of a particular transcription factor per cell is relatively low, and while 
antibodies might work well for Western Blot or immunolocalization, their behavior in the 
ChIP approach is usually uncertain. Thus to make sure that ChIP can be done effectively 
in our hands, we decided to also perform ChIP on post-translational histone marks, which 
comprise abundant epitopes, and for which ChIP-grade antibodies exist. Because Zfh1 
was predicted to be a transcription repressor, we thought it would be useful if we chose 
H3K27me3, a repressive histone mark. If we were successful, the ChIP-qPCR results 
might then be compared for HA-Zfh1 and H3K27me3 as these might exhibit a positive 
correlation.    
      We have carried out multiple trials for the H3K27me3 ChIP-qPCR. It was clear that 
the histone mark ChIP was working, although with some variation among trials (Fig.9A). 
We reproducibly observed higher binding enrichment on all eya sites, compared to mys 
and shg. The enrichment at eya by H3K27me3 matched with our previous prediction, as 
Eya should be repressed in Zfh1 expressing cells. However, the potential situation for shg 
might be more complex. While we showed E-Cadherin expression in hub cells was 
suppressed by ectopic Zfh1 protein, it is known that E-Cadherin can still accumulate in 
Zfh1 overexpression testes (42). Thus, we must also consider the possibility that shg 
would actually not be repressed in zfh1 expressing cells. The relative depletion on shg 
sites observed from H3K27me3 ChIP-qPCR was potentially consistent with the fact that 
E-Cadherin was present in Zfh1 overexpression testes.  
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• IgG ChIP-qPCR results demonstrate low background  
      As a negative control, IgG ChIP-qPCR was also carried out multiple times. Signals 
for IgG ChIP-qPCR were significantly lower than that for H3K27me3 and HA-Zfh1 ChIP 
(Fig.9A, B, C), suggesting low background in our experiments. Similar to the results for 
H3K27me3, we also observed variation in the absolute amount of target DNA 
precipitated comparing different trials.  However, within each trial, the results for all the 
primer sets were very similar (Fig.9B). This matched with our expectation, as anti-IgG 
should pull down chromatin non-specifically.  
• ChIP on testes with tagged Zfh1  
      The HA-Zfh1 ChIP-qPCR results were tricky to interpret. We felt confident to say 
that Zfh1 bound to eya and shg (Fig.9C, D). The binding also appeared more consistent 
on the eyaA3 sites compared to eyaC1, even though the genetics might have suggested 
stronger association with C1 compred to A3.  
There are two ways to analyze ChIP-qPCR data. One is to express the data by 
calculating “% of Input”, which compares results for ChIP’ed chromatin with the Input 
(un-ChIP’ed). The other is to express the data by “fold change”, which calculates the 
signal of HA-Zfh1 ChIP relative to negative control (IgG) ChIP. We applied both 
methods to analyze our HA-Zfh1 ChIP data (Fig.9C, D). If the ChIP is performed 
successfully, an expected qPCR signal for a transcription factor is in the range of 0.05-0.3% 
of Input, and 5-fold change (PGFI ChIP-Seq Workshop). Thus we took 0.05% of Input, 
or a 5-fold change as a measure of significance when examining the plotted data. For 
primers of eyaA3-5 and shg-346-1, we reproducibly observed an enriched signal in every 
trial no matter which analysis method was used. Thus we conclude that the binding on 
these two sites is real. For other primers applied, there was often variation among trials. 
But in general, the binding on eyaA3 sites tended to be more consistent than eyaC1 sites, 
which was opposite to what we expected (see Discussion). We took into account that 
signal differences observed in ChIP-qPCR might be due to biological variation within 
each batch of testes processed. But, if one focuses on the data within one trial, there were 
consistent results using different primer pairs representing the same gene fragement. For 
example, eyaA3-4 and eyaA3-5 were two different primer pairs targeting Ebox2 of 
eyaA3. The results for using these two primers were pretty similar within each trial. This 
suggested strongly to us that each individual experiment was of good quality.  
• The anti-HA antibody used in HA-Zfh1 ChIP experiments is specific   
      To investigate the specificity of the antibody against HA, we also performed ChIP-
qPCR on Nanos>Upd testes, samples with the same phenotype as Zfh1 overexpression 
testes but lacking any HA epitope. We expected to see relatively reduced qPCR signals 
on these negative control testes. Given the signal variation in ChIP-qPCR experiments, 
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we compared results of experiments that were performed at a similar time. For anti-HA 
ChIP, signals on the negative control Nanos>Upd testes were often 4 times lower than 
those on the positive control EyaA3>3×HA-Zfh1 (Fig.9E). For ChIP controls in these 
experiments, anti-H3K27Me3 and anti-IgG ChIP, signals on Nanos>Upd samples were 
on the same order, and followed the same trend as EyaA3>3×HA-Zfh1 (Fig.9F, G). Thus, 
we concluded the rabbit anti-HA used in ChIP experiments is specific. 
 
The size distribution of sequencing libraries prepared from ChIP’ed chromatin has 
an aberration   
      We have prepared libraries for the sequencing part of the project. We could 
reproducibly make libraries from Input (un-ChIP’ed) chromatin. As assayed by 
BioAnalyzer, the size distribution of such libraries was enriched for a single peak in the 
200-300bp region (Fig.10A), which was perfect for sequencing. However, for libraries 
prepared from ChIP’ed chromatin, we often observed two peaks on the BioA graph 
(Fig.10B). The lower-sized peak was similar to what was observed in Input libraries, with 
the correct size and concentration for sequencing. The second peak, representing a higher 
molecular size, should not be present, and it may interfere with the sequencing. To 
address this problem, we discussed potential solutions with experts in the Functional 
Genomics Core. There were two possibilities for the nature of the DNA comprising the 
additional upper peak. The first was that it represents a pool of larger DNA fragments in 
the ChIP’s samples. The ChIP protocol involves extensive sonication to reduce chromatin 
size. Perhaps the size distribution of our initial chromatin was too broad, and we had 
larger than desirable DNA size among the ChIP’ed chromatin. We therefore size-selected 
the already generated libraries. This method got rid of the additional upper peak 
(Fig.10C), but at the same time also unavoidably reduced the concentration of the sample 
below the minimum requirement for sequencing. 
      A second possibility was that the upper peak represented DNA concatamers 
assembled from multiple smaller (and appropriate) sized chromatin fragments. This can 
occur as one outcome of a PCR step during library preparation, where a low PCR primer 
concentration may cause the formation of concatamers. One way to bring concatemers 
back to individual chromatin was to re-do the PCR for two cycles with freshly added 
primers. We also tried this alternative trouble-shooting method. But the upper peak did 
not disappear in the subsequent BioA analysis (data not shown).  
      We have prepared enough samples using the first trouble-shooting method, and are 
waiting in the queue to have our samples sequenced.  
 
Genetic modifier Screen for Zfh1  
      A modifier screen is a powerful genetic approach to identify suppressors and 
enhancers of the phenotype caused by sustained Zfh1 expression. Ideally, such a screen 
would involve reducing the gene dose for some factor necessary for Zfh1 to act, or to 
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antagonize Zfh1 function. Thus, to conduct a successful modifier screen, a sensitized 
background is preferred, where the extent of phenotype is likely to be manipulated by the 
dosage of genes. The testes used for ChIP-Seq purposefully had an extreme phenotype, as 
extra CySCs and GSCs filled the entire testis. Such a phenotype would not be ideal for a 
modifier screen, since a potential suppressor or enhancer may not be able to influence it. 
Thus we conducted a time course experiment to visualize the progression of the stem cell 
tumor phenotype caused by sustained Zfh1 expression. We hoped to identify a stage 
when the testes had a moderate phenotype. I will state our findings, and our screen plans 
below.    
 
The stem cell tumor phenotype develops progressively from the tip of testes   
      In order to obtain the full blown stem cell tumor phenotype, crosses for generating 
flies with ectopic Zfh1 expression were set up at 18oC to avoid the lethality caused by 
Zfh1 overexpression during development. The suppression of Gal4-UAS system was 
achieved by the expression of a temperature sensitive allele of Gal80 (Gal80ts), which 
repressed the Gal4 function at the permissive temperature (18oC). Young flies that 
eclosed from the crosses were shifted to 29oC to inactivate Gal80ts function, and allow 
the expression of Gal4-UAS (and, thus Zfh1). 12 days after aging at 29oC, bright DNA 
staining, a marker for actively dividing cells, were observed throughout the entire testis, 
and the testes were enriched with extra CySCs and GSCs (Fig.11E).  
      In the time course experiment, we examined the presence of bright DNA staining in 
testes aged for various times at 29oC (Fig.11A). At 3 days after induction of Zfh1 bright 
DNA was still generally restricted to the testis tip, similar to samples prior to the 
temperature shift (Fig.11B, C); but at 6 days of Zfh1 expression, the bright DNA region 
had expanded to the middle of the testis tube (Fig.11D). We quantified the area of bright 
DNA staining using ImageJ (see Materials and Methods). As shown in Fig.11F, the 
fraction of testis filled with bright DNA increased steadily as testes were aged at 29oC for 
longer periods of time. We noted some variation of the phenotypic strength among testes 
grown under the same conditions and aged for the same period. However, this variation 
did not obscure the general trend (Fig.11G). Thus, we concluded that phenotypic 
progression depended on how long ectopic 3×HA-Zfh1 had been expressed.  
 
Design and current progress of the screen  
      The results from the time course experiment suggested that testes aged at 29oC for 6 
days were a better background in which to conduct the modifier screen. We hypothesized 
that by analyzing the fraction of testis filled with bright DNA, we could identify 
modifiers in either direction. For example, a suppressor or enhancer could either shrink or 
expand the region with bright DNA staining in 6-day testes, making those 6-day testes 
appear more like 3-day or 12-day samples, respectively. Note that a phenotypic 
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“suppressor” in this genetic experiment (where we are reducing gene dose) would 
encode a positive factor acting along with Zfh1.   
      To test this basis of our screen, we first carried out a pilot, using mutant alleles for 
genes predicted to play a role downstream of (or in collaboration with) Zfh1. Our 
previous results showed that Zfh1 was a transcriptional repressor in testes, and ectopic 
Zfh1 in cyst lineage initiated BMP ligand expression to guide GSC renewal. Thus genes 
chosen for the pilot screen included CtBP (a known co-repressor of Zfh1), Punt (a BMP 
receptor), and Med (a BMP transducer), Dally Dlp (BMP co-receptors). Results showed 
that with only one copy of CtBP, testes aged at 29oC for 6 days had a reduced fraction of 
bright DNA (Fig.12). This was consistent with what we expected, since CtBP was also 
required for CySC maintenance and Zfh1 function (42). We did not observe a change of 
phenotype when the dose of components of BMP pathway was reduced (Fig.12).   
      To conduct the modifier screen, we decided to use deficiency lines from Exelixis 
library. Each line has molecularly defined end-points, and collectively, the lines cover 
about 50% of genes on the 3rd chromosome (103). Thus, if any positives were identified, 
we should be able to easily test each of the annotated genes contained within the 
deficiency in order to identify the relevant gene. We have screened 26 lines so far. 
Df(3L)Exel6101 may be a potential hit (data not shown) but further experiments are 
needed to verify its candidacy.  
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-PB is longer than Zfh1-PA, with two additional zinc 
towards the N-terminus. In Drosophila embryo
zfh1-RA were detected.  
 
 each has 
-
s, zfh1-RB and 
the 
  
Figure 4. Tagged UAS-Zfh1
control line with N-terminally 3×HA tagged UAS
resulting in ectopic HA expression (red, A’) in a pattern of stripes. Notice endogenous 
Zfh1 (green) was not predominantly expressed in HA+ region. (B, C) When driven by 
Patch-Gal4, either N- (B) or C
exhibited ectopic HA expression (red, B’, C’). Antibodies against Zfh1 could also detect 
the ectopic protein (green), as Zfh1 staining now overlapped with HA (yellow). The 
patterning of embryos overepxressing Zfh1 appeared misorganized, the much smaller 
size of HA+ cells in C’ indicated that these cells were undergoing apoptosis.  
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-RB can be expressed properly in embryos. (A) A positive 
-STAT was driven by Patch
- terminally (C) 3×HA tagged UAS
 
-Gal4, 
-Zfh1-RB lines 
 
  
Figure 5. The N-terminally 3×HA tagged UAS
CySCs at 100% penetrance and with high expressivity. (A) The control testis with a cyst 
lineage Gal4 expression (eyaA3
GSCs near the hub (FascIII, A”), 
fusomes (α-Spectrin, A”
terminally 3×HA tagged UAS
GSCs (Vasa+ cells with dotted 
The stem cell tumor phenotype was present in all testes scored (n=24). (C, D) Ectopic 
HA expression was detected in the entire testis with tagged Zfh1 expression (D), but not 
in Gal4 only control testis (C). Images of A and B were taken using 40x lens, whereas C 
and D were snapshots under 10x. 
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-Zfh1-RB gives rise to ectopic GSCs and 
-Gal4) only had CySCs (Zfh1+ cells, A’) and 
with most germ cells (Vasa+, A’) exhibiting branched 
, arrows). (B) When overexpressed in the cyst lineage, N
-Zfh1-RB caused ectopic CySCs (Zfh1+ cells, B’) and 
α-Spectrin staining, B’, B”, arrows) throughout the testis. 
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Figure 6. Rabbit anti-HA can immunoprecipitate (IP) 
tagged Zfh1-PB from testis lysates. (A) Using an 
antibody against HA developed in rat, a dominant 
band with the size similar to that predicted for Zfh1
PB was detected in whole cell lysates isolated from 
Zfh1 overexpression testes (arrow). A specific band 
also appeared for testis sample overexpressing tagged 
STAT (arrowhead), a positive control for the 
experiment. No band was detected in lysates isolated 
from w1118 embryos. (B) IP was performed 
following the ChIP protocol (the flow chart). Zfh1 
overexpression testes were used, but they were not 
treated with formaldehyde to cross
link chromatin and 
protein. Using a 
commercial ChIP
anti-HA antibody raised 
in rabbit, the tagged 
Zfh1 could be pull
down (lane 7). The 
tagged proteins could 
also be tra
each step of the protocol 
(lane 1-6). (C) Results for another 
IP trial. The specific Zfh1 band was present 
in the IP’ed sample (arrow), but not in the 
post IP supernatant. For the positive 
control sample with tagged STAT 
overexpression, a band specific to STAT 
was also present in the IP’ed sample 
(arrowhead).  
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Figure 7. eya and shg (E
and eyaA3-LacZ were reporter lines of two regulatory fragments of 
of eyaC1-LacZ was restricted to 
CySCs where Zfh1 was expressed (A, green). In contrast, eyaA3
entire cyst lineage, including Zfh1+ cells (B, green) and differ
drawn white curved line). (C) E
expression (red) was low 
the expression of E-Cadherin (white) was reduced.    
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-Cadherin) may be putative targets of Zfh1. (A, B) eyaC1
eya
differentiating cyst cells (A, red, bracket), but not in 
-LacZ was present in the 
entiating cyst cells (B, 
-Cadherin (white) was enriched in hub cells, where Zfh1 
(arrows). (D) When ectopic Zfh1 was expressed in the hub (red), 
 
 
-LacZ 
. The expression 
  
Figure 8. Primers designed for ChIP
from studies performed by Bonini 
from a Zfh1 ChIP-chip experiment using 
downstream of shg-346 and mys
(CACCTG) to which Zfh1 binds was identified using DNASTAR. 
(red) derived from qPCR prim
PCR fragment close to 100bp. 
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-qPCR. The sequences of eyaC1 and eyaA3 came 
et al. (101), and shg-346 and mys-772 were identified 
wildtype embryos (100)
-772 were from Flybase. The presence of Ebox site 
Predicted a
ers designed that flanked each EBox site, with the size of 
 
. Sequences 
mplicons 
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Figure 9. ChIP-qPCR results. (A) The H3K27me3 ChIP
sites, compared to mys and shg. (B) Signals in IgG ChIP
(notice the different scales of the Y-axis). (C, D) Analys
fold change (D). The minimum point of the Y
represent successful ChIP-qPCR (PGFI ChIP
eyaA3-5 and shg-346-1. In general, the binding on eyaA3 sites tended to be more consistent than eyaC1 sites. (E
Comparison of ChIP-qPCR results using either tagged Zfh1 overexpression testes (blue, red
overexpression testis (black bar). For anti
overexpression testes (E). For anti-H3K27Me3 and anti
and followed the same trend as EyaA3>3×HA
77 
-qPCR reproducibly showed higher binding enrichment on all eya 
-qPCR was much lower than either H3K27me3 or HA
is of HA-Zfh1 ChIP-qPCR using two approaches: % of Input (C), and 
-axis was set to either 0.05 (C) or 5 (D), an accepted cutoff threshold thought to 
-Seq Workshop). Signal enrichment was reproducibly observed for primers of 
, and green bars) or JAK
-HA ChIP, signals on Nanos>Upd testes were often 4 times lower than those on Zfh1 
-IgG ChIP, signals on Nanos>Upd samples were on 
-Zfh1 (F, G).   
 
-Zfh1 ChIP 
-G) 
-STAT 
the same order, 
  
 
Figure 10. The size distribution of sequencing libraries prepared from ChIP’ed chromatin 
has an aberration. (A) Libraries prepared from Input (un
enrichment in the 200-300bp region. This pattern of size distribution was perfect for 
sequencing. (B) Libraries generated from HA
the BioA graph, with a second peak representing a higher molecular 
selection, the additional upper peak disappeared, but the concentration of the sample was 
also unavoidably reduced (data not shown). 
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-ChIP’ed) chromatin exhibited an 
-Zfh1 ChIP’ed chromatin had two peaks on 
size. (C) After size
 
 
-
  
Figure 11. The stem cell tumor phenotype caused by Zfh1 overexpression develops 
progressively from the testis tip. (A) The schematic design of the time course experiment. 
(B-D) The bright DNA region (green) was expanded gradually from the tip of the testis 
(bracket, drawn white curved lines), as tagged ectopic Zfh1 (red) was sustained
Statistical measurement of the fraction of testis filled with bright DNA at each time point. 
(F) A scatter plot of the measured bright DNA fraction for each testis in the time course 
experiment. 
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. (E) 
  
Figure 12. Results of Zfh1 
repressor of Zfh1), Punt (a BMP receptor), and Med (a BMP transducer), Dally Dlp 
(BMP co-receptors). Genotypes are: 3×HA
and 3×HA-Zfh1/eyaA3
(Experimental).   
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pilot screen. Genes shown here are: CtBP (a known co
-Zfh1/eyaA3-Gal4; +/tubulin
-Gal4; mutant allele of selected gene/tubulin
 
-
-Gal80ts (Ctrl), 
-Gal80ts 
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Discussion 
      The transcription factor Zfh1 is an important stem cell regulator in Drosophila testes 
(42). Here we attempt to identify target genes of Zfh1 using two complementary 
approaches, ChIP-Seq and a genetic modifier screen. We generated an N-terminally 
3×HA tagged UAS-Zfh1-RB line, which proves to be an appropriate reagent for carrying 
out ChIP using anti-HA antibodies. Results from our preliminary ChIP-qPCR 
experiments showed that Zfh1 was enriched at sequences from the regulatory region near 
shg and eya. We also found that the ability of Zfh1 to cause a stem cell tumor was 
reduced under conditions where the co-repressor CtBP was impaired. These preliminary 
results demonstrate the feasibility of the two independent approaches.     
 
How are excess stem cells induced in Zfh1 overexpression testes? 
      The stem cell tumor phenotype resulting from Zfh1 overexpression is dramatic. The 
development of ectopic stem cells (CySCs and GSCs) involves dedifferentiation, a 
process in which differentiated cells revert to stem cells. Understanding how 
dedifferentiation occurs in vivo will aid in elucidating the mechanism of tissue 
regeneration. In our experiments, ectopically produced Zfh1 protein was restricted to the 
cyst lineage. However, Zfh1 overexpression also influenced the neighboring germline 
lineage, as excess GSCs were induced. This non-autonomous effect of Zfh1 demonstrates 
that one type of stem cell can serve as a niche, producing factors to control the 
maintenance of another stem cell population. Studying signals that guide the behavior of 
the second stem cell lineage will further aid our understanding in stem cell-niche biology.  
      For these reasons it is intriguing to consider how the phenotype in Zfh1 
overexpression testes is developed simply by manipulating the expression of a single 
gene. Albeit oversimplified, it is reasonable to dissect the question into three sub-
questions: 1) which cell stage generates the de novo stem cells? 2) how do de novo stem 
cells proliferate to create the stem cell tumor? 3) and, what is the non-autonomous 
mechanism that induces GSCs? We do not have definitive answers to these questions. 
But observations made in the time course experiment may have given us some clues. 
Below I will discuss the three sub-questions respectively, and present some speculation.  
      We think the de novo cyst stem cells are generated by de-differentiation from early-
stage cyst cells. The Gal4 driver used to express Zfh1 ectopically will drive Zfh1 
expression in all cyst cells, even late-stage cyst cells normally associated with meiotic 
germ cells. In fact, epitope-tagged Zfh1 was visible throughout the entire testes, even 
after only 3 days of Zfh1 expression. However, the bright DNA signal, a marker for 
actively dividing cells, was initially restricted to the apical tip of the testis, where the 
endogenous proliferation center is located. Only after Zfh1 was expressed for longer 
periods, did the region of bright DNA gradually expand further down the testis. We 
conclude that not all somatic cells ectopically expressing Zfh1 are converted into stem 
cells. This, in turn, suggests that cells at different developmental stages of a lineage have 
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differential potential to change back to stem cells. Obviously here, cells closer to the 
endogenous pool of stem cells have stronger potential to become stem cells. Because all 
cyst cells, the differentiating progeny of CySCs, have exited from cell cycle, the fact that 
they re-initiate division suggests that they have regained some stemness properties. These 
potential candidates are also cells that are at an earlier stage of differentiation; for 
example, they have exited the cell cycle only very recently. This observation is consistent 
with previous findings in the field. It has been shown that early rather than late stage 
germ cells (spermatogonia) can dedifferentiate to become GSCs (49). Thus, in a similar 
manner, among cyst cells now expressing Zfh1 the early stage cells may be easier to 
convert back to CySCs.  
      As for the second sub-question, it is reasonable to think that the generation of the 
stem cell tumor is caused mainly by continuous proliferation of de novo stem cells. The 
newly formed stem cells as described above are constantly dividing. Normally, in the 
testis system, the division of stem cell is often asymmetric, as one daughter retains 
stemness, whereas the other starts to differentiate (32). However, in Zfh1 overexpression 
testes, since the CySC determinator is expressed in the entire lineage, the fate of a newly 
produced daughter cell should also be stem cell, and the progeny of this daughter cell 
retain the stemness too. Thus, their continued division in this manner can account for the 
tumor.   
      It is worth mentioning that we occasionally observed a small patch of cells exhbiting 
brightly staining DNA in the middle of the testes, spatially disconnected from the 
proliferating cells at the testis tip (data not shown). This suggests that occasionally late 
stage cyst cells can be converted back to CySCs, perhaps if Zfh1 expression has been 
maintained for long enough. In the future, this possibility should be examined more 
closely to determine whether late-stage dedifferentiation might contribute to tumor 
formation.    
      For the third sub-question, recall that the induction of new GSCs relies on the 
successful generation of new CySCs. Thus, it is reasonable to think that early cyst cells 
which are more prone to become CySCs play a role to coax nearby spermatogonia to 
dedifferentiate into new GSCs. We found that germ cells with dotted fusomes, a marker 
for GSCs, were not observed in excess in testes 3 or 6 days after Zfh1 induction (data not 
shown). Therefore, we think the dedifferentiating germ cells do not adopt GSC fate 
immediately. Rather, germ cells may first regain the property of division, producing more 
cells similar to them. As Zfh1 expression remains high in the neighboring somatic cells 
(now becoming CySCs), the actively dividing germ cells then gradually become bona 
fide GSCs. How this two-step (or even multi-step) conversion correlates with changes 
happening as cyst cells convert into true CySCs is unknown.  
 
Can Zfh1 be a transcriptional activator?  
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      The HA-Zfh1 ChIP-qPCR result shows that Zfh1 appeared enriched near shg, the 
gene encoding the Drosophila homologue of E-Cadherin. Since Zfh1 is predicted to be a 
transcriptional repressor, this binding suggests that E-Cadherin is suppressed in Zfh1 
overexpression testes. However, in Zfh1-overexpressing testes, Judy Leatherman found 
that E-Cadherin actually accumulated in Zfh1+ cells. This is not consistent with the idea 
that Zfh1 is repressing E-Cadherin expression. In addition, H3K27me3, a repressive 
histone mark, also appears relatively depleted in shg regulatory region. Thus how do we 
explain the conflicting findings? One possible explanation is that Zfh1 is generally acting 
as a repressor in testes, but its binding near shg is not functional because other nuclear 
partners that would be required for effective repression are not recruited to the shg site. 
Therefore the expression of shg is not suppressed in spite of the binding of Zfh1. Another 
possibility is that Zfh1 may actually function as a transcriptional activator at some target 
genes, such as shg. One argument against this may be that E-Cadherin is suppressed by 
ectopic Zfh1 in hub cells. However, the presence of other DNA-binding proteins as well 
as transcription co-factors around the regulatory region of shg may be quite different in 
hub cells and CySCs, thus the effect of Zfh1 on shg in these two different cell types may 
be different. It has been shown that many transcription factors can work as both 
repressors and activators depending on promoter and cellular context, as well as 
availability of other proteins (105). Thus it is possible that Zfh1 may serve as a 
transcriptional activator for shg in CySCs.   
      The possibility that Zfh1 may be a transcriptional activator can also help to explain 
the perplexing results for eyaA3 and eyaC1. The expression of eyaA3-LacZ is present in 
both CySCs and cyst cells, whereas eyaC1-LacZ is only expressed in cyst cells. Since 
Zfh1 was originally thought to be a transcriptional repressor, we hypothesized Zfh1, 
normally enriched in CySCs, would bind more effectively to C1 than A3, accounting for 
C1 repression in CySCs.  Therefore we expected that C1 would exhibit a higher relative 
enrichment than A3 in the Zfh1 ChIP. However, enrichment of HA-Zfh1 to A3 appeared 
to be more consistent than to C1. The confounding results can be explained if Zfh1 can 
also act as a transcription activator. Zfh1 can then bind to A3, and activate its expression 
in CySCs. The reciprocal expression pattern of C1 and Zfh1 may be explained as a 
coincidence, only indicating the possible binding. Nevertheless, previous genetic data 
show that Eya is suppressed in Zfh1+ cells, and my own H3K27me3 ChIP-qPCR support 
this idea. We think this can be explained by the fact that there exist multiple eya 
regulatory elements (101). Thus the regulation of eya expression may be complex, 
involving other elements and proteins, and is not dictated solely by A3 and Zfh1.   
      Another argument against the notion that Zfh1 may be a transcriptional activator is 
that reduced expression of CtBP, the co-repressor of Zfh1, dampens stem cell tumor 
phenotype. This observation can be explained by two possibilities. One is that CtBP may 
also instead function as a co-activator in Zfh1+ cells. In Drosophila, in vitro and in vivo 
experiments have demonstrated that monomers of CtBP activate some Wingless targets, 
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whereas dimers repress the expression of other genes (106). Thus CtBP can be a co-
activator depending on its oligomeric state. The other possibility is that Zfh1 can serve as 
both an activator and a repressor in CySCs, depending on which gene it regulates, that is, 
on context of its binding sites, or of other regulatory factors involved. Recently, strong 
data from Eileen Furlong’s lab has shown that snail, a well-established transcriptional 
repressor during Drosophila embryogenesis can also function as an activator for other 
target genes in the same type of cells (107). Thus, it is possible that Zfh1 may also play a 
dual role in CySCs.    
 
Are there better approaches to identify direct targets of Zfh1? 
      The ChIP-qPCR experiment on H3K27me3 demonstrates that we can execute a ChIP 
experiment successfully, at least for relatively abundant histone marks. Our results on 
HA-Zfh1 ChIP-qPCR, while suggestive, have been somewhat inconclusive. The 
sequencing of libraries should provide us with more potential positive controls, and those 
can be used for further refining the experimental procedure to successfully carry out ChIP 
for Zfh1. Nevertheless, there exist two major limitations of the HA-Zfh1 ChIP-qPCR 
experiment, which may prevent us from obtaining successful and comprehensive ChIP-
Seq results. First, it is intrinsically difficult to perform ChIP on a small number of cells, 
which is what we are attempting to do here. Second, the positive controls chosen for 
ChIP-qPCR come from a gene list generated by a Zfh1 ChIP-chip experiment conducted 
on wildtype embryos. This experiment was carried out in a large scale cis-regulatory 
annotation project, so the gene list has not been verified by those investigators using 
ChIP-qPCR and anti-Zfh1 (100). In addition, that work used an antibody against Zfh1, 
one that we have not been able to verify as working in our embryo ChIP (see Addendum). 
For these reasons, we cannot be certain that the genes we selected are definitively 
“positive controls”. Because of these caveats to our current ChIP-Seq experiment, it is 
worthwhile thinking about alternative approaches to identify direct targets of Zfh1.  
      A modified version of ChIP is to FACS sort zfh1 expressing CySCs and conduct 
ChIP starting from a pure population of cells. In the current ChIP-qPCR experiments, 
testis samples are used, therefore, a lot of cells without Zfh1 expression also go into the 
ChIP. The high amount of chromatin from these cells may interfere with the specific 
binding of the antibody. In contrast, the FACS method can produce an enriched pool of 
zfh1 expressing cells. This would allow the antibody to have a higher chance of 
recognizing the correct epitope during ChIP. We have generated flies with tagged UAS-
Zfh1 and UAS-GFP. This reagent will be useful for performing the GFP-based FACS 
before ChIP.  
      An alternative approach to identify direct targets of Zfh1 is DamID (DNA adenine 
methyltransferase identification). DNA adenine methylation is widely present in bacterial 
genomes, but not in eukaryotes. When the Dam enzyme is fused to a transcription factor, 
and expressed in eukaryotic cells, DNA near the binding site of the transcription factor 
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will be modified by the tethered Dam (108). The detection of the modification can be 
achieved by Methyl PCR. A specific antibody against the transcription factor is not 
required in DamID, thus the method is not restricted by the quality of an antibody reagent. 
We have obtained the UAS construct to make Dam fused with Zfh1, and it should not be 
straight-forward for us to try this alternative approach.  
 
Speculation on whether the short isoform of Zfh1 can also cause excess stem cells  
      In the course of our work, we discovered that two Zfh1 isoforms are present in testes, 
and these have different lengths. Here we showed that the long isoform can cause stem 
cell tumor phenotype. Due to a complication (see Addendum), we do not know whether 
the short isoform can also generate extra stem cells. However, there is indirect evidence 
to suggest that it can. We have detected the expression of both isoforms in testes 
overactivated for the JAK-STAT pathway, which are full of extra CySCs and GSCs (data 
not shown). Furthermore, using RNA-Seq, Gan et al. have shown that the short and long 
transcripts of zfh1 are expressed at similar levels in bam mutant testes, which are 
enriched with early stage germ cells including GSCs (109). These data demonstrate that 
the short isoform is indeed present in stem cell-enriched testes, and suggest that it might 
contribute to the phenotype. We have generated new UAS constructs for the short 
isoform. Thus we can use these newly synthesized tools to directly test the capability of 
the short isoform to induce stem cells. Because the short isoform misses two additional 
zinc fingers and a polyQ region at the N-terminus compared to the long isoform, the 
result would suggest us whether those protein motifs play a role in the Zfh1 
overexpression experiment.     
 
Material and methods 
Fly strains  
      Fly lines used were: FRT82B zfh165.34, FRT82B zfh175.26, and UAS-stat-HA (Erika 
Bach, New York University, USA), MARCM 82B, and upd-Gal4 (Erika Matunis, John 
Hopkins University, USA), UAS-hoptumL (Norbert Perrimon, Harvard University), nanos-
Gal4:VP16 (Erica Selva, University of Delaware, USA), CtBPDE10 (Ken Cadigan, 
University of Michigan, UAS). All other stocks were provided by the Bloomington Stock 
Center or generated in this study. Flies were grown at 25ºC unless noted.  
      For Zfh1 genetic modifier screen, 215 lines from Exelixis deficiency library were 
ordered. Since multiple crosses were needed to generate the appropriate fly stock for the 
screen, we further cut down the number of deficiency lines to 188 by excluding lines with 
smaller deletion and nested in those with bigger deletion.  
 
Plasmids 
      The construct of UAS-Zfh1-RA-1×Flag-1×HA came from BDGP (Berkeley 
Drosophila Genome Project). To make plasmids with tagged version of UAS-Zfh1-RB, 
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we sequenced the cDNA constructs from BDGP (Berkeley Drosophila Genome Project), 
and identified two point mutations and a 586bp deletion in exon4. Using site-directed 
mutagenesis (Agilent Technologies), we corrected the point mutation. Using restriction 
enzyme digestion and ligation, we repaired the deletion with a fragment from another 
zfh1 cDNA construct. The flawless zfh1-RB sequence was cloned into various pUAST 
destination vectors (developed by Terence Murphy, DGRC) using Gateway 
recombination methods (Invitrogen). Transgenic flies were produced using standard 
germline transformation techniques.  
 
Immunostaining  
      Immunostaining for adult testes and embryos was performed as previously described 
except 1×PBS was substituted for Buffer B (Leatherman and DiNardo, 2010). The 
following antibodies were used: mouse anti-lacZ (1:10,000, Promega), rat anti-E-
Cadherin (1:20, DSHB), goat anti-Vasa (1:400, Santa Cruz), mouse anti-FascIII (1:50, 
DSHB), rabbit anti-α-Spectrin (1:200, DSHB), chick anti-GFP (1:1000, Molecular 
Probes), rat anit-HA (1:200, Roche), mouse anti-Myc (1:500, Santa Cruz). For anti-Zfh1 
staining, 1:5000 and 1:500 were usually used for adult testes and embryos, respectively. 
The following antibodies have been used to visualize Zfh1: rabbit anti-Zfh1 (Ruth 
Lehmann, New York University, USA), rabbit anti-Zfh1 (Kevin White, New York 
University, USA), guinea pig anti-Zfh1 (James Skeath, Washington University in St. 
Louis).  
 
Imaging and imaging analysis 
      Images were captured with a Zeiss Axioplan 2 equipped with an apotome. Z-series 
were analyzed by the AxioVision 4.6 software. The quantification of bright DNA on 
testis snapshot was conducted using ImageJ (NIH) by following a procedure similar to 
previously described (110).  
 
Western Blot  
      The Western Blot was performed as previously described except that testes were 
lysed using 2×SDS-PAGE sample buffer (111). Because the size of Zfh1-PB was 
predicted to be about 145kDa, 7.5% Tris-HCl gel (Bio-Rad) was used to better visualize 
the protein. Antibodies used were rat anti-HA (1:1000, Roche), and mouse anti-actin 
(1:1000, Invitrogen).   
 
Immunoprecipitation 
      The IP protocol was similar to ChIP, except that 60 pairs of testes were used per IP, 
and the collected testes were often not cross-linked by formaldehyde.  
 
ChIP 
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      ChIP was conducted using EZ-Magna ChIP A-Chromatin Immunoprecipitation Kit 
(Millipore). 80 pairs of testes were used per ChIP.  
 
qPCR 
      The qPCR experiment was performed using Brilliant SYBR Green QPCR Master 
Mix (Agilent Technologies). Primers were designed using DNASTAR and Primer3. 
Following the manufacturer’s protocol, the qPCR fragment size was determined to be 
about 100bp. We tested primer pairs on Input (un-ChIP’ed) samples first, and then 
checked the product size on 2% agarose gel. The qPCR data was analyzed by Excel 
(Microsoft).  
 
Library preparation for sequencing 
      Sequencing libraries were prepared using NEBNext DNA Library Prep Master Mix 
Set for Illumina (NEB).   
 
Cell culture 
      Experiments related to cell culture were performed as previously described (111).   
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Summary 
     The Drosophila male germline system is an excellent model to study niche-stem cell 
biology. Extensive work in the field has demonstrated that signals provided by the niche 
play a crucial role in regulating the behavior of GSCs (44-46, 50-53). Among those 
identified signals, the JAK-STAT pathway has received most attention (44, 45). A model 
which involves a single niche has also been dominant in the field. The studies presented 
here as well as recent work in our lab emphasize the importance of another signaling 
pathway, BMP, and also modify the niche-stem cell model (40). We characterize the role 
of Magu as a novel BMP modulator specifically required for GSC maintenance. The 
function of Magu may also depend on its interaction with heparan sulfate proteoglycans. 
Previous work in the lab identified the transcription factor Zfh1 as a key regulator for 
both CySCs and GSCs (42). We have attempted to identify downstream targets of Zfh1 
using two genome-wide approaches. Preliminary results suggest that Zfh1 can function as 
either a repressor or activator to control the expression of target genes. Together, these 
findings further reveal the complexity of the seemingly simple niche system in the fruit 
fly testis. Below I will discuss two interesting questions related to the Magu project. I 
will also address remaining questions and future experiments for the ongoing project on 
Zfh1.   
 
How is BMP activity restricted to the stem cell niche?  
     The BMP signaling pathway is conserved in both invertebrates and vertebrates. 
Studies in various model organisms (Drosophila, Xenopus, and Zebrafish) have 
demonstrated that secreted BMP ligands are able to diffuse over a long distance across 
tissues (112). This diffusion usually builds a gradient of ligand concentration to guide 
tissue patterning (112). Contrary to this classical view, BMP activation in fruit fly testes 
is often restricted to within one cell diameter from the ligand source, near where the stem 
cell niche is located (50-52). In other words, BMP signals function over a short range to 
specifically regulate GSC self-renewal. The restriction of BMP activity is necessary in 
the testes, as expanded BMP activation blocks the differentiation of gonial cells (50-52). 
Therefore, studying how BMP activation is restricted in this niche can further enhance 
our understanding of how niche signals are controlled.   
     One possibility for signal restriction is that pathway activation may be localized to the 
niche-stem cell interface. Recently, Michel et al. developed a fluorescent reporter for the 
activation of BMP type I receptor Thickvein (63). Using this tool, they have 
demonstrated that BMP signals from the hub are specifically received at the hub-GSC 
interface, where adherens junctions are located (63). We have also found that when 
overexpressed in the germline in an otherwise wildtype background, Dally-like (Dlp), a 
co-receptor for BMP ligands, is enriched at the hub-GSC interface. This specific 
localization is disrupted in magu mutant testes, as Dlp appears more diffuse around the 
entire germ cell surface. Since BMP activation is impaired in magu mutant testes, it is 
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possible that Magu functions to concentrate Dlp at the hub-GSC interface, and that 
concentration is necessary for proper pathway activation. In the future, we can investigate 
the direct interaction between Magu and Dlp by testing whether these two proteins can be 
co-immunoprecipitated from testes.    
     Another possibility to explain restricted activation is that pathway activity may be also 
governed by other pathways. It has been shown in multiple systems that BMP signaling 
restricts stem cell activation by suppressing Wnt signaling (113, 114). Thus, it is 
reasonable to speculate that there may be unidentified signaling at the testis niche that 
antagonizes BMP activation and restricts its function to the niche. We think results 
coming from the Zfh1 project would reveal additional pathways important for GSC self-
renewal. We can then test whether BMP activity is expanded when any of newly 
identified pathways is impaired.  
 
Can magu be a target gene of Zfh1?  
     Previous work in our lab has suggested that BMP pathway is activated non-
autonomously in GSCs by sustained Zfh1 expression in the cyst lineage (40). Since Magu 
is an extracellular protein required for BMP activation in GSCs, it is possible that Magu 
functions downstream of Zfh1 activation, and may be a target of Zfh1. Due to the limited 
resolution of in situ hybridization in fly testes, we cannot be certain whether magu is 
expressed in CySCs, where zfh1 is expressed. Thus, whether magu is a direct target of 
Zfh1 remains unknown.   
     Since Zfh1 is expressed in many other tissues, there might be other occasions where 
Magu acts along with or downstream of Zfh1. For example, magu is expressed 
prominently in embryonic neuroblasts (data not shown). This expression pattern may 
overlap with zfh1, which is also expressed in neuroblasts (115). But further experiments 
with double staining are needed to determine whether the two genes are expressed in the 
same neuroblasts. Since, Zfh1 mutant embryos exhibit a defect in motor neuron 
projection (98), we should also investigate whether magu mutant embryos have a similar 
phenotype.   
 
How to prioritize the gene list generated by HA-Zfh1 ChIP-Seq? 
     The sequencing of libraries prepared from the HA-Zfh1 ChIP experiment is currently 
underway. We expect the resulting gene list will be long, thus it is important to prioritize 
the results for follow-up analysis. We will first rank the genes using the relative level of 
Zfh1 enrichment. We will then search for regions containing Ebox sites, which are 
known motifs that Zfh1 binds to (91). After these in silico analysis, we will visualize the 
expression pattern of selected genes in testes. This attempt can be fulfilled by in situ 
hybridization, or by using antibodies in those cases where one exists, or analyzing an 
enhancer trap line for those genes that have one associated with them. Because our ChIP-
qPCR experiments suggest that Zfh1 may function as either a transcriptional repressor or 
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activator, we will look for genes that either specifically expressed in CySCs (where Zfh1 
is expressed) or in differentiating cyst or hub cells (where Zfh1 is not expressed). The 
efforts to prioritize putative Zfh1 targets will also be complemented by results coming 
from the ongoing modifier screen. We think candidates suggested by both approaches 
have a higher chance to be a real target.  
 
What effectors would be Zfh1 targets?   
   Genome-wide approaches have been taken in studies of Drosophila testis. In a previous 
microarray experiment, we identified genes enriched in JAK-STAT overexpression testes. 
Such genes included Zfh1 and Magu (64). The Fuller lab conducted a gain-of-function 
screen by overexpressing individual genes in the germ cells using a set of transgenic lines, 
each capable of expressing a neighboring gene using the Gal4 system. Their analysis 
uncovered the role of the differentiation factor called Bam (51). Thus, in our lab’s and the 
Fuller Lab’s work, novel genes influencing early stages of spermatogenesis have been 
identified. Thus, whole-genome approaches in the testis can generate new insights on 
stem cell regulators. Below I will state possible effectors of Zfh1, based on its dual 
function and other information.  
     We think there are two groups of effectors downstream of Zfh1: one governs CySC 
fate intrinsically, and the other controls how CySCs act non-autonomously as niche cells 
for GSC self-renewal. For genes belong to the first group, when their normal function is 
disturbed, mutant CySCs would lose the stemness and differentiate. For the second group 
of effectors, they would be specifically required for GSC maintenance, but not in CySC 
stemness. Therefore, if effectors in the first group are impaired, Zfh1 overexpression 
testes will not exhibit ectopic stem cells, neither CySCs nor the GSCs that rely upon them. 
However, extra CySCs but not GSCs will still be induced if genes in the second group are 
mutated.  
     It is worth mentioning that since ectopic stem cells in Zfh1 overexpression testes 
undergo active division, we expect some targets of Zfh1 would be regulators of the cell 
cycle. In addition, it has been shown that ZEB1, the mammalian homolog of Zfh1, 
negatively regulates expression of stemness-inhibiting microRNAs (116, 117). Thus 
some effectors of Zfh1 may also be microRNAs. Recently, Kadaja et al. discovered that 
Sox9, a newly identified transcriptional regulator for hair follicle stem cells, binds to 
genes encoding extracellular factors that promote TGFβ/Activin signaling (118). 
Therefore, secreted signaling factors (for instance, ligands for BMP or any unknown 
pathway) may be Zfh1 effectors.   
 
How to further investigate dedifferentiation in Zfh1 overexpression testes?  
     The excess stem cells induced by ectopic Zfh1 are likely generated through 
dedifferentiation. In the Discussion session of Chapter 3, I speculated on how the 
dedifferentiation process could occur based on current knowledge in the field. To 
 92 
 
elucidate the process definitively in the future, the combined approaches of 
immunofluorescent staining on fixed tissue and time-lapsed imaging of live testes should 
be applied. According to the time course experiment for Zfh1 overexpression testes, 
dedifferentiating cyst cells regain the capacity of cell division, a property of CySCs. To 
further confirm the identity of these cells, markers of stem cells should be used. It has 
been shown that Hedgehog signaling is required for CySC self-renewal (46, 53). Thus we 
can use Hh readouts to check pathway activation in somatic cells under division. We can 
also stain testes with antibodies against Eya, a marker for differentiated cyst cells. 
Findings from these experiments can tell us the status of cyst cells when converting into 
CySCs. Similarly, for the germline lineage, we can further investigate the identity of 
dividing germ cells using the differentiation marker Bam as well as GSC marker Escargot. 
The previous time course experiment suggested that majority of dedifferentiating germ 
cells are not bona fide GSCs at 6 days after Zfh1 activation. Thus the time point we will 
focus on to observe the first onset of de novo GSCs may be later than 6 day.  
     While examination on fixed testes can tell us important characters of dedifferentiating 
cells, it is likely that the actual process of dedifferentiation can be quite dynamic, and 
some key features of the process may not be revealed using fixed samples. Thus live 
imaging is a complementary approach to study the generation of excess stem cells. As 
mentioned in Chapter 3, the morphology of differentiated cyst cells and spermatogonia 
has to be changed dramatically in order to revert to stem cells, thus I think reagents that 
mark cell outlines would be revealing tools for live imaging. We can drive UAS-
membrane GFP using either cyst or germline lineage Gal4 to visualize the real-time 
behavior of cells. During dedifferentiation, cells would rearrange so that newly generated 
CySC and GSC can associate with each other. This process may involve cell movement. 
The motility of cells may be acquired through actin-based protrusions. Therefore, it may 
be also useful to visualize cell behavior using actin-based constructs.  
 
How to test that Zfh1 is a transcriptional activator?   
     Results from our HA-Zfh1 ChIP-qPCR experiments suggest that Zfh1 may function as 
a transcriptional activator. This finding contradicts the stereotypical model of Zfh1, 
which describes it as a transcriptional repressor (91). To further test the capability of 
Zfh1 to activate transcription, several follow-up experiments are needed.  
     First, to investigate how the gene expression profile is controlled by Zfh1, a RNA 
microarray or RNA-Seq experiment should be performed. Ideal, this type of experiment 
would be conducted comparing wildtype to zfh1 depleted testes. Since Zfh1 is an 
essential gene, we cannot use genetic mutants for such an experiment. I have tried to 
knock down Zfh1 in adult testes by RNAi, but without great success (see Addendum). 
Therefore, the only expression profile that can be obtained effectively is from comapring 
wildtype to zfh1 overexpression testes. If the expression of a gene is positively regulated 
by Zfh1, then its expression should be increased dramatically in zfh1 overexpression 
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testes compared to wildtype. If such gene also ranks high on the ChIP-Seq list, it is likely 
that its transcription is directly activated by Zfh1.     
     Second, to further confirm the direct activation of certain genes by Zfh1, we would 
use both in vivo and in vitro experiments. We can generate zfh1 mutant clones in testes, 
and then visualize whether the expression of a putative target is lost in the mutant cell. It 
is likely that regulatory fragments of some putative targets have been identified by other 
work in the field, and certain regulatory sequence may overlap with the binding region 
identified from ChIP-Seq experiment. Thus to ascertain Zfh1’s control to those regions, 
we can perform luciferase assay in Drosophila S2 cells using reporter constructs 
including such regulatory fragments. In the case that regulatory fragments do not already 
exist, we can generate the necessary constructs by PCR amplification guided by the 
region identified from the HA-Zfh1 ChIP-Seq. If Zfh1 controls gene expression 
positively, the activation level of the reporter line would be higher when co-transfected 
with Zfh1.   
     Third, to determine how Zfh1 controls transcription activation, its binding site needs 
to be verified. There are two types of DNA-binding motifs in Zfh1: zinc fingers and a 
homeodomain. It has been shown that zinc fingers of Zfh1 bind to Ebox site to suppress 
transcription, whereas the homeodomain may activate transcription via binding to the 
sequence GCTAATTG (94, 119-125). We have identified a putative binding sequence for 
the homeodomain within the eyaA3 region but not in C1 (data not shown). This seems 
consistent with our conclusion that Zfh1 activates the A3 fragment rather than C1. To test 
the importance of the homeodomain binding site, we can mutate its sequence in A3 and 
examine whether that alters A3-lacZ expression pattern.  
     Another possibility for how Zfh1 acts as an activator is that it may bind to a de novo 
motif. Recent study from the Eileen Furlong lab has demonstrated that snail, a stereotypic 
transcriptional repressor, can directly activate expression of different genes in the same 
type of cells (107). They further demonstrated that the decision of repression or activation 
is encoded in the target gene sequence, as the presence of a novel motif that Snail binds 
to is essential for potentiating gene expression (107). Thus, we should also compare the 
regulatory region of genes either activated or repressed by Zfh1, and attempt to discover 
any novel, recurring motifs in them.   
     Lastly, to further elucidate the mechanism of transcriptional activation governed by 
Zfh1, we can try to identify nuclear partners interacting with Zfh1. ZEB1 is the 
mammalian homolog of Zfh1. It has been shown that ZEB1 can bind to transcriptional 
co-activators p300 and P/CAF, thereby promoting transcription as a complex (126, 127). 
Hence we can also test whether Zfh1 interacts with these co-activators by performing Co-
IP experiments using zfh1 overexpressing testes. Another way to identify proteins 
associated with Zfh1 is to conduct mass spectrometry analysis on protein samples IP’ed 
by antibodies against Zfh1 (128). Chromatin modifiers are another type of key player for 
transcriptional activation (105). Although transcription factors like Zfh1 may or may not 
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directly interact with chromatin-remodeling complex, the two parts are mechanistically 
linked (105, 128). Thus we think the mass spectrometry experiment can either identify 
chromatin modifiers with a direct physical link with Zfh1 or proteins mediating the 
connection between Zfh1 and chromatin-remodeling complex. In either case, the 
experiment would further enhance our understanding of how Zfh1 may act as a 
transcriptional activator.  
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1. Additional efforts to investigate Magu’s involvement in BMP  
      We attempted to demonstrate the involvement of Magu in BMP signaling pathway by 
multiple approaches. Although the results of the following experiments did not serve the 
initial purpose, they might be informative to future work in the lab, and thus are included 
here.  
 
A. the effect of activation of Sog in magu mutants 
      Sog is an extracellular antagoniss of BMP signals. To test whether the overexpression 
of Sog in a magu mutant background would further reduce GSC numbers, we 
overexpressed Sog using nanos-Gal4 in mague00439/maguf00256. There was no discernible 
difference between mague00439/maguf00256;nanos-Gal4/UAS-sog and mague00439/maguf00256 
(Addendum Table 1). However, since the activation of Sog failed to cause a phenotype in 
magu heterozygotes, it was unclear whether the overexpression of Sog had been achieved 
in this experiment.  
 
B. Other read-outs of BMP activation in testes 
      Besides using pMad accumulation as a readout for the BMP pathway, the activation 
of two other proteins involved in BMP signaling was also tested. Medea is the protein 
that forms a complex with pMad. The Mad-Medea complex translocates into the nucleus, 
and regulates expression of target genes. Specific staining of Medea was observed in 
some wildtype testes (data not shown), but the accumulation was in hub cells, not GSCs. 
Medea also accumulated in late stage cyst cells. This is expected, as BMP signaling is 
activated in those cells as previously reported (62).   
      Dad is a target gene of BMP activation, and it negatively regulates BMP signaling. 
BMP signaling in the Drosophila wing disc is routinely monitored using Dad reporter 
lines, including Dad-LacZ, and a newer tool, Dad-RFP (129). Similar to Medea and 
pMad, there was no reliable LacZ detection in GSCs in testes with two copies of dad-
LacZ (data not shown). It was unclear whether the GSC staining observed in 3rd instar 
larvae gonads was specific, since the signal was also present in spermatogonia (data not 
shown). For Dad-RFP, the staining was blazingly bright on certain big-size sheath cells 
(Appendum Fig.1A; these are pigment cells). The specific staining of Dad-RFP also 
appeared in hub cells (Addendum Fig.1A’, arrowhead), and cyst cells (Addendum 
Fig.1A’, arrow). Similar to magufrgII-LacZ (Fig.1B, Chapter 2), the expression in hub 
cells sometimes was not uniform, as only a fraction of hub cells had the RFP staining 
(Addendum Fig.1B, B’).  
      Because none of these assays was sensitive enough to detect BMP activation in GSCs 
in wildtype adult testes, I did not proceed to use them as a way to test BMP reduction in 
magu mutants.     
   
C. UAS-tor-Tkv UAS-tor-Punt, another BMP activation construct 
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      Tkv and Punt are the Type I and II receptors of BMP signaling pathway in 
Drosophila. Two different transgenic lines of flies have been used to activate the BMP 
signaling pathway. The first is an amino acid change in Tkv, the type I receptor. All the 
Nanos>TkvA testes had overproliferation cysts (Addendum Fig.2A, arrow), an expected 
phenotype of ectopic BMP activation in testes (50, 52). The second transgenic setup 
overexpresses both the type I and type II receptors UAS-tor-Tkv UAS-tor-Punt (130). 
Both constructs have been shown to cause constitutive transducing activity in other 
tissues (130, 131). However, only one-third of the Nanos>tor-Tkv tor-Punt testes 
exhibited the phenotype of overproliferation cysts (data not shown). Therefore, I chose to 
rescue magu mutants using UAS-TkvA.  
 
2. Additional comments on pMad staining  
      As a positive control for pMad staining, it is worth noting that pMad activation in 
germ cells was consistently detected in testes with ectopic BMP activation in the 
germline (Addendum Fig.2B). Still, we could never observe consistent GSC 
accumulation of pMAD in wildtype testes, nor among GSCs of Magu overexpression 
testes (upd>V5-magu, data not shown). The other situation where a nice pMad staining 
on GSCs was reproducibly observed was testes with either JAK-STAT activation or Zfh1 
overexpression in the cyst lineage (data not shown). In both situations, the testes were full 
of ectopic GSCs and CySCs (see Chapter 3 for details). 
      Recently, Li et al. reported a protocol for better pMad staining in Drosophila wing 
disc (132). Different from ours, the protocol used twice higher formaldehyde in the 
fixation buffer and supplemented phosphatase inhibitor for each step. We applied this 
protocol on wildtype testes. We did observe pMad staining in GSCs in most testes scored 
(data not shown). Because germ cells could not be visualized well in this particular trial, 
we could not test whether the pMad staining was present in every GSCs. In addition, 
there were many nonspecific dots on the testes in the pMad channel, and we did not know 
what caused that.  
 
3. Drifting hub phenotype due to UAS-dlp-GFP  
      When the activation of dlp-GFP was sustained in hub cells for a long time (12 days, 
29 oC), we observed a hub drifting phenotype, in which the apically located hub cells 
appeared far away from the testis tip (Addendum Fig.3C, arrow). This phenotype 
occurred in all 9 control testes scored (magu heterozygotes). However, the drifting hub 
was also observed in 6 out of 10 UAS-dlp-GFP only testes, although the new position of 
the hub appeared closer to the tip compared with Gal4-UAS samples (Addendum Fig.3A). 
We do not know whether this phenotype was simply due to genetic background, or 
whether UAS-dlp was leaky; though I could detect no specific GFP staining in Gal4 only 
testes. 
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Addendum Table 1.  The effect of activation of Sog in magu mutants 
 
Condition Genotype a 
 
Median 
GSC #  
 
 
IQR b 
 
Min - 
Max c 
P value d 
 
aged at 29oC 
for 3 days f 
magu[e] / magu[f] ; nanos-Gal4 or UAS-sog/MKRS 3 (11) e 0 - 4 0 - 6  
 
magu[e] / magu[f] ; nanos-Gal4/UAS-sog 
 
3 (11) 
 
1.5 - 4 
 
0 - 6 
 
>0.05 
aged at 29oC 
for 13 days g 
magu[e] or [f]/CyO; nanos-Gal4 or UAS-sog/MKRS 5 (9)  5 - 5 3 - 8  
 
magu[e] or [f]/CyO; nanos-Gal4/UAS-sog 
 
6 (9) 
 
4 - 6 
 
3 - 10 
 
>0.05 
a Alleles used: [e]=[e00439]; [f]=[f02256]. 
b
 interquartile range = Quartile 3 - Quartile 1 (Q[3] - Q[1]), Q[3] = the 75th percentile, Q[1] = the 25th 
percentile.  
c Minimum - Maximum, representing the spread of GSC numbers observed 
d Calculated by Mann-Whitney test. 
e
 Number of testes scored in parentheses 
f
 Animals (0-3 days of age) raised at 25oC were shifted to 29oC for 3 days. 
g Animals (0-6 days of age) raised at 25oC were shifted to 29oC for 13 days. 
 99 
 
 
Addenudm Figure 1. dad-RFP does not exhibit expression in GSCs. (A) In one reporter 
line of dad (dad-RFP, 5n), the expression was present in hub cells (arrowheads), cyst 
cells (arrow), and big-size pigment cells on the testis sheath. (B) In the 6f line of dad-
RFP, the expression in the hub (E-Cadherin, white) appeared restricted to a fraction of 
hub cells (B'). 
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Addendum Figure 2. BMP signaling can be activated properly in the germline using a 
constitutively activated form of Type I receptor Thickvein. (A) When UAS-TkvAct was 
driven in the germline using nanos-Gal4, testes appeared to have overproliferation cysts 
with more than 16 spermatogonia (arrow). (B) The ectopic activation of BMP pathway 
could be detected by pMad staining (red) throughout the testis. 
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Addendum Figure 3. A drifting hub phenotype appears when UAS-dlp-GFP is 
expressed in hub cells using hh-Gal4 for 12 days. (A) In 6 out of 10 UAS-dlp-GFP only 
testes, the apically located hub cells (FascIII, white) exhibited away from the testis tip. (B) 
This phenotype had a higher penetrance in Gal4-UAS testes, present in all 9 testes scored. 
(C) The mislocalized hub in Gal4-UAS testes often appeared very far away from the 
apical tip, as visualized by anti-GFP under 5X.  
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1. Indirect activation of zfh1 through JAK-STAT signaling pathway fails to generate 
a high fraction of testes enriched with functional CySCs (and extra GSCs) 
     There are two ways to activate JAK-STAT signaling in the cyst lineage. One is to 
overexpress an activated form of JAK (JAKAct), the signal transducing kinase, using a 
cyst lineage Gal4; the other is to ectopically produce Upd, the secreted ligand, in the 
germ cells using Nanos-Gal4. Either of these approaches should generate testes with 
large number of bona fide CySCs, intermingled with many GSC-like cells (Addendum 
Fig.1B) (42). A previous postdoc in the lab took the first approach using EyaA3-Gal4, a 
commonly used cyst lineage driver. She used these JAK-STAT overactivation testes for 
the ChIP experiment. Her results suggested that we could successfully perform Zfh1 
ChIP on testes. However, I could not repeat her data (data not shown), and, in re-
examining her raw data, discovered some errors in the qPCR protocol and in analysis of 
qPCR results.  
     In addition, I examined EyaA3>JAKAct testes in more detail. I found that the majority 
of testes did not have functional, ectopic CySCs, as suggested by the lack of extra GSCs 
(Addendum Fig.1A). In these testes, the zfh1+ cells often formed patches, with the 
presence nearby of groups of spermatogonia and even spermatocytes (Addendum Fig.1C). 
To confirm this observation, I also tried to drive UAS-JAKAct using two other cyst 
lineage drivers, c587-Gal4 and Tj-Gal4. Although the percentage of testis with excess 
CySCs and GSCs in those two overexpression samples was higher than the 
EyaA3>JAKAct group, the stem cell tumor phenotype was far less than 100% penetrant 
(Addendum Fig.1A). I also scored functional CySCs phenotype in Nanos-Gal4 UAS-Upd 
testes. Similar to what had been reported, only half of the overexpression testes had extra 
GSCs (45). In summary, all these findings led us to conclude that indirectly activating 
zfh1 through JAK-STAT pathway did not cause functional zfh1+ cells in every testis, and 
this may be the reason why Zfh1 ChIP did not work when using such testes. 
 
2. Direct activation of zfh1 using untagged UAS-Zfh1-RB also does not cause enough 
extra zfh1+ cells 
     We also tried to increase the number of zfh1+ cells directly. There existed an untagged 
UAS-Zfh1-RB line generated by Postigo et al. The construct of this transgenic fly was 
made from zfh1 cDNA plasmid prepared by Fortini et al. (Flybase) (91). When compared 
with information in Flybase, the originally published zfh1 cDNA sequence has deletions 
in the polyQ region (opa) and another point mutation (120). It is unclear whether Postigo 
et al. corrected these sequence aberrations when generating the UAS-Zfh1-RB construct 
(Flybase) (91). Nevertheless, this UAS-Zfh1 line can supply normal Zfh1 function to 
rescue defects on glia cells in zfh1 mutant embryos (97). We also used this line 
previously to demonstrate that sustained Zfh1 in the cyst lineage caused excess CySCs 
and GSCs.  
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     I overexpressed Zfh1 using the Postigo’s UAS-Zfh1 and various cyst lineage Gal4 
drivers. As shown in Addendum Fig.1A, the percentage of testis with extra CySCs and 
GSCs was even lower than the JAK-STAT activation approach. This was similar to what 
we had noticed before (Judy Leatherman, personal communication). We do not know 
whether the sequence aberrations in the untagged UAS-Zfh1-RB decrease the ability of 
Zfh1 to generate excess stem cells, even thought the construct can rescue zfh1 mutant 
phenotypes. Because of the low penetrance of the phenotype, I did not bother to try Zfh1 
ChIP on testes expressing this form of Zfh1.  
 
 3. UAS-Zfh1-RA-1×Flag-1×HA fails to cause extra stem cells in testes    
     When the epitope tagged short isoform of Zfh1 was expressed in the cyst lineage 
using either EyaA3-Gal4 or c587-Gal4, we did not observe ectopic CySCs nor GSCs 
(Addendum Fig.2B). The testes did not have extra zfh1+ cells, and the presence of 
branched fusomes in germ cells suggested normal spermatogenesis, just as in wildtype 
testes. This was in contrast to the positive control, which was the expression of untagged 
(Postigo’s) UAS-Zfh1. In this case dotted fusomes accumulated at the tip of testis 
(Addendum Fig.2A).  
     Extensive efforts were made to trouble shoot this problem. We sequence verified the 
entire transgene for both the plasmid from BDGP and genomic DNA isolated from 
transgenic flies. To further test whether the transgene can be expressed in vivo, we 
overxpressed UAS-Zfh1-RA-1×Flag-1×HA using En-Gal4, a driver with a stripe pattern 
on embryos. We could only observe the ectopic expression using anti-Zfh1 (Addendum 
Fig.2C), but not using an antibody against the epitope tag (either Flag or HA, data not 
shown). Western Blot using anti-HA also did not detect the tagged Zfh1 in protein lysates 
isolated from En>Zfh1-RA-1×Flag-1×HA embryos (Addendum Fig.2D). This suggested 
that tagged Zfh1 proteins were not generated appropriately. Consistent with this idea, 
embryos expressing Zfh1-RA-1×Flag-1×HA looked morphologically normal (rather than 
disorganized, as embryos expressing Zfh1-RB, Fig.3 in Chapter 3), although they did not 
survive to the larval stage. We also attempted to visualize the ectopic expression in vitro, 
using transfection into cultured cells. However, S2R+ cells transfected by Ubi>Zfh1-RA-
1×Flag-1×HA failed to show HA staining (data not shown). Together, these experiments 
suggested strongly that UAS-Zfh1-RA-1×Flag-1×HA could not be expressed properly, 
and it would not be useful for Zfh1 ChIP experiments. 
     We do not know why UAS-Zfh1-RA-1×Flag-1×HA is not expressed well. In the 
construct, there is an extra fragment between Zfh1-RA and 1×Flag-1×HA (Addendum 
Fig.2E. This fragment contains a stop codon and needs to be spliced out in vivo, to allow 
the in-frame expression of Flag and HA. We suspect that the splicing may not happen 
successfully. This may cause the misfolding of newly synthesized ectopic Zfh1 protein, 
or the improper translation of epitope tags.  
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4. Epitope-tagged UAS-Zfh1-RB lines cause stem tumor phenotype in various 
degrees  
     In Chapter 3, we reported that an N-terminally 3×HA tagged UAS-Zfh1-RB gave rise 
to stem cell tumor phenotype at 100% penetrance and high expressivity. We have also 
investigated other epitope-tagged UAS-Zfh1-RB lines. We found out that a C-terminally 
3×HA tagged UAS-Zfh1-RB line only caused ectopic HA+ cells, but did not generate 
extra GSCs as shown by the presence of branched rather than dotted fusomes in germ 
cells (Addendum Fig.3A). For the N-terminally 6×Myc tagged UAS-Zfh1-RB line, 
ectopic Myc expression was present in every testis scored, but only the testis tip region 
exhibited a mild GSC tumor phenotype (Addendum Fig.3B). Similarly, although the 
penetrance of ectopic Myc+ cells was 100% for the C-terminally 6×Myc tagged UAS-
Zfh1-RB line, only 36% of the testes examined had a mild GSC tumor phenotype at the 
tip region (Addendum Fig.3C).  Additionally, testes looked thinner compared to the Gal4 
only control testes.  
     The variation we observed among different tagged UAS-Zfh1-RB lines was expected. 
The genomic insertion sites of the transgenes were likely quite different from each other, 
and the identity and position of the tag could also pose an effect on the function of the 
ectopic protein. 
 
5. Available antibodies against Zfh1 may not be useful for ChIP  
     Four labs had independently generated antibodies against Zfh1. These antibodies were 
mapped to a similar region of the protein (Addendum Fig.4). One of them, made by the 
Kevin White lab, was used for Zfh1 ChIP-chip on wildtype embryos (100), but the data 
from that experiment has not been confirmed yet. So it is unclear whether the available 
antibodies against Zfh1 were useful for ChIP. We performed immunofluorescent staining 
on embryos and testes using three of the four anti-Zfh1 antibodies (we did not use the one 
generated by the Lai lab). We determined that these three antibodies all recognized Zfh1 
proteins nicely in the two tissues by immunofluorescence (data not shown). However, 
when we applied the antibodies developed by the labs of Ruth Lehmann and Kevin White 
for ChIP experiments on either embryo or testis samples, we did not observe a positive 
result (data not shown). Therefore, we concluded these anti-Zfh1 antibodies may not 
work for ChIP of Zfh1.     
     It is worth pointing out that the ChIP experiments described above all suffer from the 
fact that we may not have a bona fide positive control region to assay for successful ChIP 
(see Chapter 3 Discussion).  
 
6. Antibodies generated by our group do not work  
     When we initially started the ChIP project, our idea was to carry out the ChIP using 
two different anti-Zfh1 sera. By focusing on regions common to both sera we would 
increase our chances of focusing on true in vivo targets of Zfh1, rather than spurious 
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enrichments. Based on this rationale, a former postdoc in the lab generated an antibody 
against a largely non-overlaping epitope as well as to a similar region as the other 
available Zfh1 antibodies (96). I made extensive efforts to test the fidelity of the new 
antibodies using immunofluorescent staining and Western Blot, but no positive results 
could be obtained (data not shown). Therefore, I went back to sequence the plasmids used 
for generating these antibodies. Unfortunately, the sequence of the epitopes was not 
present in the construct.  
     We also attempted to generate a monoclonal antibody against the same epitope as the 
anti-Zfh1 developed by the Ruth Lehmann lab. This work was outsourced by a company 
(Abmart). We received six tubes of ascites powder from the company. Each individual 
tube sample represented antibodies from an independent clone. While reconstituting the 
powder to obtain the original antibody-rich ascites fluid, we had trouble to get two of the 
six samples (C177 and C252) dissolved well. A summer college student working in the 
lab tested the remaining four clones by immunofluorescent staining, but we did not 
observe a specific staining on wildtype testes (Justin Sui, data not shown). I also tested 
the four clones on protein lysates isolated from EyaA3>3×HA-Zfh1 testes by Western 
Blot. The antibody generated from B100 clone seemed to detect a high molecular band 
with the size of Zfh1, but signal was low, and there was too much background signal to 
be confidant of this result (data not shown). The positive control (the polyclonal anti-
Zfh1 generated by the Lehmann lab) exhibited a prominent Zfh1 band on the Western 
Blot (data not shown). Thus, we do not think the newly generated monoclonal anti-Zfh1 
was useful. 
 
7. Other negative controls for ChIP-qPCR experiment besides IgG ChIP 
     When performed ChIP-qPCR, we also carefully thought about negative controls. As 
described in the Results session, ChIP on IgG was used as a quality control for non-
specific pull-down. We have also attempted to design negative control primers for the 
qPCR experiment. Since transcription factors usually do not bind to exonic regions, we 
thought primers targeted to that region may serve as negative controls for each selected 
gene. However, results showed that signals for these presumed negative control primers 
appeared indistinguiable from those targeted to regulatory regions of a gene (data not 
shown). We reasoned that because the size of the chromatin fragments that were going to 
be pulled down usually ranged from 100bp to 2kb, it is possible that the sequence of an 
exonic region may also be present in the IP’ed fragments, and thereby showed an 
enrichment in qPCR analysis.     
 
8. Zfh1 cannot be knocked down efficiently using RNAi  
     An alternative way to identify Zfh1 targets was to compare gene expression in testes 
with zfh1 knock-down to wildtype testes. Genes with differential expression profiles in 
the two testis samples were potential targets of Zfh1. Thus we have attempted to knock 
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down zfh1 expression by RNAi. There existed two RNAi lines for zfh1. Using various 
cyst lineage Gal4 drivers, we found out that only the line generated from VDRC (Vienna 
Drosophila Rnai Center) could successfully suppress zfh1 expression. However, the 
knock-down efficiency was low and the severity of the phenotype was variable. 80% of 
the 66 testes scored looked normal, similar to UAS-Zfh1-RNAi only control testes 
(Addendum Fig.5A). For the remaining 20% experimental testes, some had a reduced 
number of Zfh1+ cells at the tip (Fig.5B), while others did not have Zfh1+ somatic cells 
at all (Addendum Fig.5C). When testes were abolished for Zfh1+ cells, germ cells started 
to clump and occupy all the space around the hub (Addendum Fig.5C). It seemed that 
hub cells were now Zfh1 positive in these tests. This was likely a consequence of the shift 
to non-permissive temperature for Gal80ts, because hub cells often accumulated more 
Zfh1 when testes were grown at 29oC for a long time. One other, perhaps odd, result was 
that in Zfh1 knock-down testes some germ cells also appeared to be Zfh1+ when genuine 
Zfh1 expressing cells were not present in the testes. We did not think this was real. There 
exists a low level of Zfh1 signal in germ cells in normal testes; perhaps this simply 
“appeared” brighter since there were no longer any bona fide Zfh1 cells. At a most severe 
situation of Zfh1 knocking-down, we did not observe any type of cells inside the testes 
(Addendum Fig.5D). We did see many bright Zfh1 stainings on the testis sheath, but we 
did not know whether they were real (Addendum Fig.5D).  
 
9. Experiments to test whether N-terminally 3×HA tagged UAS-Zfh1-RB can rescue 
zfh1 mutants  
     To investigate whether the newly generated 3×HA tagged UAS-Zfh1 line was 
functionally normal, we tried to use it to rescue zfh1 mutants.  
     We first attempted to do the rescue experiment in testes. Since CySC clones mutant 
for zfh1 were not maintained, and were not detectable even 2 days after clone induction 
(42), we decided to express tagged Zfh1 in the mutant clones, and test whether this would 
rescue clone loss 4 days after induction. The MARCM (Mosaic Analysis with a 
Repressible Cell Marker) flies used for this experiment failed to generate wildtype clones 
(data not shown), thus we obtained another MARCM stock from the Matunis lab (47). 
The MARCM tool from the Matunis lab was principally the same as what we had used to 
generate zfh1 clones before. But the Matunis stock labeled clones with a membrane GFP, 
rather than a nuclear GFP. In our hands, this difference made it hard to assign the 
ownership of the GFP, since GSCs and CySCs were in direct contact with each other. 
Nevertheless, we did test this new MARCM stock thoroughly, and it could successfully 
generate both wildtype and zfh1 mutant clones (data not shown). However, we could not 
definitively establish whether the UAS-HA-Zfh1 transgene was indeed being induced in 
the zfh1 mutant cells by anti-HA (data not shown). We do not know exactly why. Maybe 
perdurance of Gal80 protein in the induced clone cells limited the amount of Gal4, so 
UAS-Zfh1 could not be activated. We are currently testing a 3rd MARCM stock.   
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     The troubles experienced in testis rescue experiments made us refer to other tissues. 
Zfh1 plays a pleiotropic role during embryonic development. We determined that in 
embryos mutant for zfh1 there was a significantly reduced number of SGPs (somatic 
gonad precursors) in the gonad. For one mutant allele, zfh165.34, the number of SGPs in 
homozygous embryos was only about one quarter of heterozygotes. We are currently 
performing experiments to rescue this phenotype by driving tagged UAS-Zfh1 using 
Six4-Gal4, a driver expressed in SGPs.  
 
10. Verification of zfh1 mutants  
     While performing the Zfh1 rescue experiment, we discovered aberrations in our zfh1 
mutant stocks. Thus we obtained fresh stocks from the Bach lab and Bloomington Stock 
Center. To better assess the strength of these zfh1 mutants, we put the mutant 
chromosome over a balancer chromosome with a novel fluorescent maker expressed in 
embryos (133). This allowed us to identify heterozygous and homozygous zfh1 mutants 
unambiguously. We discovered that residual Zfh1 protein was present in zfh12 allele (data 
not shown), similar to what had been reported before (98). There existed two EMS-
induced zfh1 mutant alleles, zfh165.34 and  zfh175.26. Broihier et al. reported that anti-Zfh1 
antibody did not recognize protein in zfh165.34 nor zfh175.26 embryos (96). However, in our 
hands, while zfh165.34 was protein null, zfh175.26 had residual Zfh1 proteins in some 
homozygous embryos with scattered staining pattern and less bright signal (data not 
shown).  
 
11. Zfh1 ChIP experiments on wildtype embryos  
     Since the White lab Zfh1 ChIP embryo list was the only source for predicting Zfh1 
targets (100), we initially decided to select putative positive control genes from the list, 
and confirm the enrichment of Zfh1 to these gene regions in our own preparations of 
embryo chromatin first. Then the positives from our embryo ChIP-qPCR experiment 
would be potential positive controls for our attempts to ChIP Zfh1 from testis chromatin. 
Based on this rationale, we also performed ChIP experiment using wildtype embryos. We 
could not get the Zfh1 ChIP worked out on embryos, even using the same antibody the 
White lab used to generate the embryo list (data not shown). However, we could 
successfully ChIP H3K27me3, the positive control (data not shown). We further read 
through protocols from other labs, and identified several steps that can be modified, for 
instance, the amount and stage of embryos collected, the concentration of formaldehyde 
used for cross-linking. We applied these modifications on our embryo ChIP experiments. 
The signal for H3K27me3 was dramatically increased, but still, the Zfh1 ChIP on 
wildtype embryos seemed not working (data not shown). 
 
 
 
  
Addendum Figure 1. Either
pathway, or direct activation of 
enough functional zfh1+ cells (CySCs). (A) Stat
excess CySCs and GSCs in various Gal4
STAT overactivation testis with extra CySCs (Zfh1+, green) and GSCs (individual Vasa+ 
cell with small size, red). (C) In some testes overexp
form of JAK (JAKAct), 
spermatogonia (interconnected Vasa+ cells with big size, red). 
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Addendum Figure 2. UAS
testes, and cannot be expressed properly 
GSCs (Vasa+ cells with dotted 
overexpressing an untagged form of Zfh1
near the hub (FascIII, white blot at the testis tip) 
overexpression testis. (C) When driven by En
RA exhibited a pattern of stripes only detectable by anti
antibody against the epitope tag (data not shown). In posi
ectopic expression of tagged STAT protein could be visualized by anti
Consistent to observations shown by immunofluorescent staining, tagged Zfh1 in embryo 
lysates could not be detected by Western Blot using anti
protein (STAT) was visible. (E) A schematic structure of the tagged UAS
construct. A fragment between Zfh1
out in vivo to allow proper expression of the tags. 
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-Zfh1-RA-1×Flag-1×HA does not cause extra stem cells in 
in vivo. (A) Ectopic CySCs (Zfh1+, green) and 
α-Spectrin staining, white) were accumulated in testis 
-RB. (B) Only endogenous CySCs and GSCs 
could be observed in Zfh1
-Gal4 in embryos, the tagged UAS
-Zfh1 (red), but not using an 
tive control embryos, the 
-
-HA, whereas the positive control 
-RA and 1×Flag-1×HA was supposed to be spliced 
 
 
-RA 
-Zfh1-
HA (green). (D) 
-Zfh1-RA 
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Addendum Figure 3. 
tagged UAS-Zfh1-
stem tumor phenotype in various 
degrees. (A) A C-terminally 3×HA 
tagged UAS-Zfh1-
ectopic HA+ cells (red), but did not 
generate extra GSCs as shown by 
the presence of branched rather than 
dotted fusomes (α-
in germ cells (Vasa, green) (n=34). 
(B) An N-terminally 6×Myc tagged 
UAS-Zfh1-RB line had ectopic 
Myc expression (red) in every testis 
scored (n=14), but only the testis tip 
region exhibited a mild GSC tumor 
phenotype. (C) The mild GSC tumor 
phenotype was also present in a C
terminally 6×Myc tagged UAS
RB line, with a 36% penetrance 
(n=22).  
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Addendum Figure 4. Various antibodies against Zfh1 generated by different labs.
existed four different antibodies against Zfh1, each mapped to a similar region of the 
protein crossing the homeodomain. Antibodies generated by the labs of Ruth Lehmann 
(RL), Kevin White (KW), and James Skeath (JS) could recognize Zfh1 proteins nic
embryos and testes (we did not test the antibody generated by Lai 
Zfh1 (RL) and anti-Zfh1 (KW) for ChIP experiment.  
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Addendum Figure 5. Zfh1 cannot be knocked down efficiently using RNAi. (A) About 
20 Zfh1+ cells (green) were clustered around the hub (FascIII, white) in UAS
RNAi only control testes. 80% of Tj>Zfh1 RNAi testes scored (n=66) exhibited a similar 
phenotype. (B-D) Remaining 20% Tj>Zfh1 RNAi testes appeared to have various 
phenotypes. Some had a reduced number of Zfh1+ cells at the tip (B), whereas others did 
not have Zfh1+ somatic cells at all (C, D). See text for detailed phenotype analysis. 
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